HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Reports

Company and asset intelligence reports

Evidence-backed intelligence reports generated from the Humanexa graph.

PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.

Company Intelligence Report

Evidence-backed company profile with competitive, portfolio, regulatory, and clinical intelligence.

Hikma

28 signals · 0 assets

28 evidence

Updated Jul 20, 2026

Aragon Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jul 20, 2026

Dizal Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jul 20, 2026

Eugia Pharma

4 signals · 0 assets

4 evidence

Updated Jul 20, 2026

Annora Pharma

5 signals · 0 assets

5 evidence

Updated Jul 20, 2026

Zealand Pharma

2 signals · 0 assets

2 evidence

Updated Jul 20, 2026

Chattem Sanofi

2 signals · 0 assets

2 evidence

Updated Jul 19, 2026

Marksans Pharma

2 signals · 0 assets

2 evidence

Updated Jul 19, 2026

InvaGen Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jul 19, 2026

ViiV Healthcare

3 signals · 0 assets

3 evidence

Updated Jul 18, 2026

Anthea Pharma

2 signals · 0 assets

2 evidence

Updated Jul 18, 2026

Accord Biopharma

3 signals · 0 assets

3 evidence

Updated Jul 18, 2026

Dr. Reddy's

6 signals · 0 assets

6 evidence

Updated Jul 18, 2026

Eisai Inc.

4 signals · 0 assets

4 evidence

Updated Jul 16, 2026

Sun Pharma

21 signals · 0 assets

21 evidence

Updated Jul 16, 2026

Amneal Pharmaceuticals

9 signals · 0 assets

9 evidence

Updated Jul 15, 2026

Boehringer Ingelheim

10 signals · 0 assets

10 evidence

Updated Jul 15, 2026

Bristol Myers Squibb

38 signals · 0 assets

38 evidence

Updated Jul 14, 2026

Crescent Pharma Limited

5 signals · 0 assets

5 evidence

Updated Jul 13, 2026

Heritage Pharma

2 signals · 0 assets

2 evidence

Updated Jul 13, 2026

Mylan

13 signals · 0 assets

13 evidence

Updated Jul 13, 2026

Zydus Pharmaceuticals

8 signals · 0 assets

8 evidence

Updated Jul 13, 2026

Novo Nordisk

7 signals · 0 assets

7 evidence

Updated Jul 12, 2026

Biocon Pharma

3 signals · 0 assets

3 evidence

Updated Jul 12, 2026

Incyte

6 signals · 0 assets

6 evidence

Updated Jul 12, 2026

Glenmark

2 signals · 0 assets

2 evidence

Updated Jul 12, 2026

Aurobindo Pharma

25 signals · 0 assets

25 evidence

Updated Jul 12, 2026

Astellas Pharma

5 signals · 0 assets

5 evidence

Updated Jul 11, 2026

Astellas

2 signals · 0 assets

2 evidence

Updated Jul 11, 2026

Ipsen

4 signals · 0 assets

4 evidence

Updated Jul 10, 2026

Mankind Pharma

5 signals · 0 assets

5 evidence

Updated Jul 10, 2026

Novartis

34 signals · 0 assets

34 evidence

Updated Jul 9, 2026

Johnson & Johnson

3 signals · 0 assets

3 evidence

Updated Jul 9, 2026

Takeda

4 signals · 0 assets

4 evidence

Updated Jul 8, 2026

Sciegen Pharmaceuticals

14 signals · 0 assets

14 evidence

Updated Jul 8, 2026

Epic Pharma

5 signals · 0 assets

5 evidence

Updated Jul 8, 2026

ACADIA Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jul 7, 2026

Hangzhou Zhongmei Huadong Pharmaceutical

2 signals · 0 assets

2 evidence

Updated Jul 7, 2026

Shanghai Junshi Bioscience

3 signals · 0 assets

3 evidence

Updated Jul 7, 2026

Lupin

10 signals · 0 assets

10 evidence

Updated Jul 6, 2026

UCB Biopharma

2 signals · 0 assets

2 evidence

Updated Jul 6, 2026

Biogen

7 signals · 0 assets

7 evidence

Updated Jul 6, 2026

Tyra Biosciences

2 signals · 0 assets

2 evidence

Updated Jul 5, 2026

Torrent Pharmaceuticals

2 signals · 1 assets

3 evidence

Updated Jul 5, 2026

Glenmark Pharmaceuticals

4 signals · 0 assets

4 evidence

Updated Jul 4, 2026

Dr. Reddy's Labs

3 signals · 0 assets

3 evidence

Updated Jul 4, 2026

Jazz Pharmaceuticals

3 signals · 0 assets

3 evidence

Updated Jul 3, 2026

Amgen

12 signals · 0 assets

12 evidence

Updated Jul 3, 2026

Deciphera Pharmaceuticals

3 signals · 0 assets

3 evidence

Updated Jul 3, 2026

Viridian Therapeutics

2 signals · 0 assets

2 evidence

Updated Jul 3, 2026

Roche

196 signals · 0 assets

196 evidence

Updated Jul 2, 2026

Strides Pharma

12 signals · 0 assets

12 evidence

Updated Jul 1, 2026

Sound Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jul 1, 2026

ANI Pharmaceuticals

3 signals · 0 assets

3 evidence

Updated Jun 28, 2026

Bayer

13 signals · 0 assets

13 evidence

Updated Jun 27, 2026

Ionis Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jun 27, 2026

Pfizer

130 signals · 0 assets

130 evidence

Updated Jun 27, 2026

Eli Lilly

70 signals · 0 assets

70 evidence

Updated Jun 27, 2026

Macleods Pharmaceuticals

10 signals · 0 assets

10 evidence

Updated Jun 27, 2026

KNOA Pharma

4 signals · 0 assets

4 evidence

Updated Jun 27, 2026

Rhodes Pharmaceuticals

5 signals · 0 assets

5 evidence

Updated Jun 26, 2026

Protega Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jun 26, 2026

Collegium Pharma

7 signals · 0 assets

7 evidence

Updated Jun 26, 2026

BioNTech SE

3 signals · 0 assets

3 evidence

Updated Jun 26, 2026

Sanofi

10 signals · 0 assets

10 evidence

Updated Jun 25, 2026

Centessa Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jun 25, 2026

Daiichi Sankyo

9 signals · 0 assets

9 evidence

Updated Jun 24, 2026

Moderna

5 signals · 0 assets

5 evidence

Updated Jun 24, 2026

Teva

25 signals · 0 assets

25 evidence

Updated Jun 23, 2026

Saptalis Pharmaceuticals

3 signals · 0 assets

3 evidence

Updated Jun 21, 2026

Cipla Ltd.

7 signals · 0 assets

7 evidence

Updated Jun 20, 2026

Novitium Pharma

15 signals · 0 assets

15 evidence

Updated Jun 18, 2026

Taro Pharmaceuticals

2 signals · 0 assets

2 evidence

Updated Jun 18, 2026

AbbVie

24 signals · 0 assets

24 evidence

Updated Jun 18, 2026

Alembic Pharmaceuticals

13 signals · 0 assets

13 evidence

Updated Jun 18, 2026

GSK

14 signals · 0 assets

14 evidence

Updated Jun 17, 2026

United Therapeutics

3 signals · 0 assets

3 evidence

Updated Jun 17, 2026

Merck

121 signals · 0 assets

121 evidence

Updated Jun 17, 2026

Sandoz

24 signals · 0 assets

24 evidence

Updated Jun 17, 2026

Regeneron

10 signals · 0 assets

10 evidence

Updated Jun 16, 2026

AstraZeneca

120 signals · 0 assets

120 evidence

Updated Jun 16, 2026

Janssen

32 signals · 0 assets

32 evidence

Updated Jun 16, 2026

Gilead

7 signals · 0 assets

7 evidence

Updated Jun 16, 2026

Alexion

5 signals · 0 assets

5 evidence

Updated Jun 2, 2026

Asset Intelligence Report

Pipeline asset assessment with regulatory timeline, competitive pressure, and linked insight synthesis.

Hospira

Pfizer · Anesthesia · Local Anesthetic

10 evidence

Updated Jul 1, 2026

Levorphanol Tartrate

Sun Pharma · Pain Management · Opioid

10 evidence

Updated Jun 28, 2026

Competitive Landscape Report

Therapeutic-area competitive map from Competitiva findings, signals, and portfolio assets.

Oncology · Monoclonal Antibody

Competitive landscape report

8 evidence

Updated Jul 20, 2026

Women's Health · Reproductive Health

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Diabetes · DPP-4 Inhibitor

Therapeutic Area Assessment

Cross-cutting therapeutic area view spanning signals, insights, regulatory precedents, and assets.

Oncology · Monoclonal Antibody

Therapeutic area assessment

8 evidence

Updated Jul 20, 2026

Women's Health · Reproductive Health

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Diabetes · DPP-4 Inhibitor

COVAC-2

Symvivo · Infectious Disease · COVID-19

10 evidence

Updated Jun 25, 2026

Levorphanol Tartrate

Acertis Pharmaceuticals · Pain Management · Opioid

10 evidence

Updated Jun 24, 2026

Lurasidone Hydrochloride

Torrent Pharmaceuticals · Psychiatry · Antipsychotic

10 evidence

Updated Jun 23, 2026

Risendronate Sodium

Aurobindo Pharma · Bone Health · Bisphosphonate

10 evidence

Updated Jun 23, 2026

Competitive landscape report

6 evidence

Updated Jul 20, 2026

Gastroenterology · Device

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Oncology · T-cell malignancies

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Surgery · Anesthesia

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Cardiovascular · Hypertension

Competitive landscape report

5 evidence

Updated Jul 20, 2026

Oncology · AKT Inhibitor

Competitive landscape report

3 evidence

Updated Jul 20, 2026

Oncology · MEK Inhibitor

Competitive landscape report

3 evidence

Updated Jul 20, 2026

Endocrinology · Rare Genetic Disorders

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Neurology · Intracranial Aneurysms

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Cardiology · Intraoperative Monitoring

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Women's Health · Mental Health

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Endocrinology · Obesity and Type 2 Diabetes

Competitive landscape report

2 evidence

Updated Jul 20, 2026

Rare Diseases · Urea Cycle Disorders

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Rare Diseases · Enzyme Replacement Therapy

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Pulmonary Arterial Hypertension · Oral Therapy

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Immunology · IL-6 Inhibitor

Competitive landscape report

3 evidence

Updated Jul 20, 2026

Orthopedics · Spine Surgery

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Endocrinology · Congenital Adrenal Hyperplasia

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Musculoskeletal · De Quervain Tenosynovitis

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Gastroenterology · Bowel Care

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Pain Management · Anesthesia

Competitive landscape report

6 evidence

Updated Jul 20, 2026

Oncology · B-Cell Non-Hodgkin's Lymphoma

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Hepatology · Antiviral

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Neurology · Epilepsy

Competitive landscape report

4 evidence

Updated Jul 20, 2026

Nephrology · Pharmacokinetics

Competitive landscape report

2 evidence

Updated Jul 20, 2026

Ophthalmology · AI Diagnostics

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Neurology · Acute Ischemic Stroke

Competitive landscape report

3 evidence

Updated Jul 20, 2026

Obstetrics · Substance Use Disorder

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Oncology · Geriatric Assessment

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Oncology · Soft Tissue Sarcoma

Competitive landscape report

2 evidence

Updated Jul 20, 2026

Dermatology · Autoimmune Disorders

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Diabetes · DPP-4 Inhibitor and Biguanide

Competitive landscape report

3 evidence

Updated Jul 20, 2026

Gastroenterology · IBS-C

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Addiction · Opioids

Competitive landscape report

1 evidence

Updated Jul 20, 2026

Oncology · Supportive Care

Competitive landscape report

18 evidence

Updated Jul 19, 2026

Neurology · Anticonvulsant

Competitive landscape report

11 evidence

Updated Jul 19, 2026

Neurology · ADHD

Competitive landscape report

8 evidence

Updated Jul 19, 2026

Oncology · Bone Metastases

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Endocrinology · Thyroid Disorders

Competitive landscape report

4 evidence

Updated Jul 19, 2026

Ophthalmology · Presbyopia

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Oncology · B-cell Non-Hodgkin Lymphoma

Competitive landscape report

3 evidence

Updated Jul 19, 2026

Oncology · B-Cell Non-Hodgkin Lymphoma

Competitive landscape report

3 evidence

Updated Jul 19, 2026

Neurology · Cognitive Impairment

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Cardiovascular · Beta Blocker

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Cardiology · Calcium Channel Blocker

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Cardiovascular · Calcium Channel Blocker

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Cardiovascular · Aldosterone Antagonist

Competitive landscape report

1 evidence

Updated Jul 19, 2026

ENT · Surgical Intervention

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Diabetes · GLP-1 Receptor Agonist

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Oncology · BTK Inhibitor

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Rheumatology · Osteoarthritis

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Cardiology · Cholesterol Management

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Hepatology · Metabolic Dysfunction-Associated Steatohepatitis

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Oncology · Bone Metabolism

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Gastroenterology · Linaclotide

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Cardiology · Beta-agonist

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Oncology · HER2-positive Breast Cancer

Competitive landscape report

5 evidence

Updated Jul 19, 2026

Respiratory · Anticholinergic

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Obstetrics · Chronic Pain Management

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Ophthalmology · Vision Impairment

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Oncology · CAR NK Cell Therapy

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Infectious Disease · Osteomyelitis

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Neurology · Developmental Language Disorder

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Pain Management · Chronic Pain

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Hematology · Vitamin K

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Reproductive Health · Hormonal Therapy

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Neurology · Schizophrenia

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Infectious Disease · HIV/HBV Co-Infection

Competitive landscape report

1 evidence

Updated Jul 19, 2026

Dermatology · Hidradenitis Suppurativa

Competitive landscape report

2 evidence

Updated Jul 19, 2026

Oncology · Oral Agent

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · Smoking Cessation

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Psychiatry · Mood Disorders

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · Glioma

Competitive landscape report

3 evidence

Updated Jul 18, 2026

Obesity · Nanoparticle Therapy

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · Nanomedicine

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Dermatology · Exosome Therapy

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Neurology · Spinal Cord Injury

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Neonatology · Oral Care

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Addiction · Nicotine

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Neurology · Depression

Competitive landscape report

9 evidence

Updated Jul 18, 2026

Immunology · IL-12/23

Competitive landscape report

4 evidence

Updated Jul 18, 2026

Immunology · IL-12/23 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Endocrinology · Hormonal Therapy

Competitive landscape report

3 evidence

Updated Jul 18, 2026

Cardiovascular · PCSK9 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Endocrinology · Diabetes

Competitive landscape report

8 evidence

Updated Jul 18, 2026

Endocrinology · Diabetes Insipidus

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Allergy · Food Allergy

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Urology · Bladder Pain Syndrome

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Gastroenterology · Inflammatory Bowel Disease

Competitive landscape report

9 evidence

Updated Jul 18, 2026

Cardiology · Hypercholesterolemia

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Infectious Disease · Antibiotic Therapy

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Cardiovascular · Dyslipidemia

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Ophthalmology · Dry Age-related Macular Degeneration

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · RET Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · EGFR Inhibitor

Competitive landscape report

4 evidence

Updated Jul 18, 2026

Oncology · PI3K Inhibitor

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Endocrinology · Growth Hormone Deficiency

Competitive landscape report

5 evidence

Updated Jul 18, 2026

Neurology · Anxiety Disorders

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Neurology · Mood Disorders

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Nephrology · Focal Segmental Glomerulosclerosis

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Hepatology · Chronic Hepatitis B

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Infectious Disease · Medical Devices

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Cardiovascular · Lipid Regulation

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Nephrology · Complement Inhibition

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Neurology · Anxiolytic

Competitive landscape report

2 evidence

Updated Jul 18, 2026

Oncology · PD-L1 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Immunology · TNF Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Oncology · BCL-2 Inhibitor

Competitive landscape report

3 evidence

Updated Jul 18, 2026

Urology · PDE5 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Psychiatry · Depression

Competitive landscape report

1 evidence

Updated Jul 18, 2026

Dermatology · Topical Retinoid

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Oncology · VEGF Inhibitor

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Respiratory · Asthma/COPD

Competitive landscape report

3 evidence

Updated Jul 17, 2026

Psychiatry · Mental Health

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Neurology · Imaging

Competitive landscape report

3 evidence

Updated Jul 17, 2026

Oncology · Radioligand Therapy

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Oncology · Lymphedema

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Cardiovascular · Atherosclerosis

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Diabetes · Drug Interaction

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Oncology · Head and Neck Squamous Cell Carcinoma

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Cardiology · Atrial Fibrillation

Competitive landscape report

5 evidence

Updated Jul 17, 2026

Cardiology · Atrial Fibrillation and Heart Failure

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Neuroscience · Depression

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Anesthesia · Injectable

Competitive landscape report

3 evidence

Updated Jul 17, 2026

Oncology · Cognitive Impairment

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Pain Management · Neuromodulation

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Gastroenterology · Drug Delivery

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Oncology · Glioblastoma

Competitive landscape report

12 evidence

Updated Jul 17, 2026

Oncology · PD-1 Inhibition

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Metabolism · Oral Drug Delivery

Competitive landscape report

1 evidence

Updated Jul 17, 2026

Oncology · CNS Lymphoma

Competitive landscape report

2 evidence

Updated Jul 17, 2026

Cardiology · Mineralocorticoid Receptor Antagonist

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Metabolic Disorders · Amino Acid Supplement

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Oncology · Radiopharmaceutical

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Pulmonology · Respiratory Distress

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Oncology · RAS Mutations

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Anesthesiology · Pediatric Pain Management

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Urology · Urinary Incontinence

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Ophthalmology · Dry Eye Disease

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Veterinary Medicine · Parasitology

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Oncology · Radiotherapy

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Gynecology · Endometrial Hyperplasia

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Not specified · Not applicable

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Respiratory · Ventilation

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Dermatology · Skin Disorders

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Nutritional Support · Parenteral Nutrition

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Obstetrics · Tocolytics

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Respiratory · Medical Devices

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Surgery · Pilonidal Sinus Disease

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Neurology · Botulinum Toxin

Competitive landscape report

3 evidence

Updated Jul 16, 2026

Oncology · Biomarkers

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Cardiology · Acute Coronary Syndrome

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Infectious Disease · Antiretroviral

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Diabetes · Oral Hypoglycemic

Competitive landscape report

6 evidence

Updated Jul 16, 2026

Pulmonary Hypertension · Prostacyclin Analog

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Electrolyte Imbalance · Magnesium Supplement

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Metabolic Disorders · Electrolyte Replenisher

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Cardiology · Radiopharmaceutical

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Neurology · Intracranial Hemorrhage

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Obesity · GLP-1 Receptor Agonists

Competitive landscape report

2 evidence

Updated Jul 16, 2026

Oncology · Rare Cancers

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Infectious Disease · Epstein-Barr Virus

Competitive landscape report

1 evidence

Updated Jul 16, 2026

Oncology · Brain Tumors

Competitive landscape report

3 evidence

Updated Jul 16, 2026

Cardiology · Diuretic

Competitive landscape report

3 evidence

Updated Jul 15, 2026

Oncology · mTOR Inhibitor

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Neurology · Myasthenia Gravis

Competitive landscape report

3 evidence

Updated Jul 15, 2026

Infectious Disease · Vaccines

Competitive landscape report

6 evidence

Updated Jul 15, 2026

Oncology · Immune Response

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Musculoskeletal · Knee Osteoarthritis

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Pediatrics · Neonatology

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Pain Management · Regional Anesthesia

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Rheumatology · Juvenile Idiopathic Arthritis

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Oncology · PD-1 Inhibitor

Competitive landscape report

11 evidence

Updated Jul 15, 2026

Oncology · Imaging Agent

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Obstetrics · Uterotonics

Competitive landscape report

3 evidence

Updated Jul 15, 2026

Nutritional Deficiency · Vitamin B12

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Nephrology · IgA Nephropathy

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Oncology · Chronic Lymphocytic Leukemia

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Oncology · CAR-T Cell Therapy

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Oncology · HER2-positive Upper Tract Urothelial Carcinoma

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Pain Management · Medical Device

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Pain Management · Medical Devices

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Cardiology · Aortic Stenosis

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Metabolic Disorders · Electrolyte Replacement

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Infectious Disease · Antimicrobial

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Psychiatry · Major Depressive Disorder

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Neurology · Niemann-Pick Type C Disease

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Oncology · RET Fusion-Positive Tumors

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Nephrology · Autoimmune Disease

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Oncology · Neuroblastoma

Competitive landscape report

5 evidence

Updated Jul 15, 2026

Oncology · Tumor Metastasis

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Diabetes · Pharmacokinetics

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Pulmonology · Smoking Cessation

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Immunology · Lupus

Competitive landscape report

5 evidence

Updated Jul 15, 2026

Pediatrics · Cholestasis

Competitive landscape report

1 evidence

Updated Jul 15, 2026

Oncology · Mental Health

Competitive landscape report

2 evidence

Updated Jul 15, 2026

Anesthesia · Neuromuscular Blockade

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Gastroenterology · H2 Antagonist

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Smoking Cessation · Nicotine Replacement Therapy

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Endocrinology · Hormone Replacement Therapy

Competitive landscape report

4 evidence

Updated Jul 14, 2026

Pain Management · Acupuncture

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Neurology · PTSD

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Ophthalmology · Myopia

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Neurology · Narcolepsy

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Oncology · CDK7 Inhibition

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Infectious Diseases · Hepatitis D

Competitive landscape report

4 evidence

Updated Jul 14, 2026

Cardiology · Heart Failure

Competitive landscape report

16 evidence

Updated Jul 14, 2026

Mental Health · Psychedelics

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Oncology · Veterinary

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Immunology · Psoriasis and Autoimmune Diseases

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Oncology · BiTE

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Immunology · Autoimmune Disorders

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Oncology · Cancer Genetics

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Hepatology · Fatty Liver Disease

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Oncology · Pancreatic Ductal Adenocarcinoma

Competitive landscape report

3 evidence

Updated Jul 14, 2026

Oncology · GIST

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Cardiology · Medical Device

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Genetic Disorders · Gaucher Disease

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Reproductive Health · Adenomyosis

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Oncology · Tyrosine Kinase Inhibitors

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Oncology · General and Metabolism · Diabetes

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Immunology · IgG4-related disease

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Endocrinology · Corticosteroid

Competitive landscape report

3 evidence

Updated Jul 14, 2026

Oncology · Urothelial Cancer

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Gynecology · Dysmenorrhea

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Ophthalmology · Age-related Macular Degeneration

Competitive landscape report

4 evidence

Updated Jul 14, 2026

Ophthalmology · Age-Related Macular Degeneration

Competitive landscape report

4 evidence

Updated Jul 14, 2026

Dermatology · Alopecia Areata

Competitive landscape report

2 evidence

Updated Jul 14, 2026

Dermatology · Alopecia Areata and Vitiligo

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Surgery · Breast Reconstruction

Competitive landscape report

1 evidence

Updated Jul 14, 2026

Cardiovascular · Antihypertensive

Competitive landscape report

9 evidence

Updated Jul 13, 2026

Dermatology · Psoriasis

Competitive landscape report

8 evidence

Updated Jul 13, 2026

Cardiovascular · Anticholinergic

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Psychiatry · SSRI

Competitive landscape report

3 evidence

Updated Jul 13, 2026

Oncology · Myeloid Cancer

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Neurology · Gene Therapy

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Cardiology · Antiplatelet

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Neurology · Carbonic Anhydrase Inhibitor

Competitive landscape report

3 evidence

Updated Jul 13, 2026

Oncology · CDK Inhibitor

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Neonatology · Bronchopulmonary Dysplasia

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Rheumatology · Rheumatoid Arthritis

Competitive landscape report

3 evidence

Updated Jul 13, 2026

Women's Health · Contraception

Competitive landscape report

6 evidence

Updated Jul 13, 2026

Neuropsychiatry · Developmental Disorders

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Endocrinology · Hormone Replacement

Competitive landscape report

7 evidence

Updated Jul 13, 2026

Obesity · Medical Device

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Nephrology · Light Chain Cast Nephropathy

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Neurology · Spinal Muscular Atrophy

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Hematology · RNA-targeted therapy

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Rheumatology · Gout

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Orthopedics · Shoulder Surgery

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Anesthesia · Sedation

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Oncology · Hodgkin Lymphoma

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Oncology · Targeted Protein Degradation

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Neurology · Major Depressive Disorder

Competitive landscape report

2 evidence

Updated Jul 13, 2026

Infectious Disease · Pneumococcal Disease

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Gastroenterology · IL-23 Inhibitors

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Pain Management · Shockwave Therapy

Competitive landscape report

1 evidence

Updated Jul 13, 2026

Oncology · Chemotherapy Support

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Chemotherapy Adjunct

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Cardiology · Surgical Procedures

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · High-Grade Glioma

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Infectious Disease · Antifungal

Competitive landscape report

3 evidence

Updated Jul 12, 2026

Electrolyte Imbalance · Calcium Supplement

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Neurology · Antidepressant

Competitive landscape report

4 evidence

Updated Jul 12, 2026

Neurology · Alcohol Use Disorder

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Neurology · Friedrich's Ataxia

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Cardiology · Cardiac Safety

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Acute Lymphoblastic Leukemia

Competitive landscape report

3 evidence

Updated Jul 12, 2026

Musculoskeletal · Knee Pain

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Pediatrics · Analgesic

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Renal · Phosphate Binder

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Smoking Cessation · Nicotine Receptor Agonist

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Neurology · Generic Drug

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Obesity · Combination Therapy

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Anesthesia · Sedative

Competitive landscape report

3 evidence

Updated Jul 12, 2026

Oncology · KRAS G12C-Positive Non-Small Cell Lung Cancer

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Cardiology · Acute Myocardial Infarction

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Neurology · Viral Infections

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Breast/Ovarian Cancer

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Pain Management · Analgesia

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Cardiovascular · Atherosclerotic Disease

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Pain Management · Solvent

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Immunology · Monoclonal Antibody

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Allergy · Nasal Spray

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Cardiovascular · Angina

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · PD-1 Inhibitor and ADC

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Nasopharyngeal Carcinoma

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Cardiovascular · Diuretic

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Neurology · Movement Disorders

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Oncology · Estrogen Receptor Modulator

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Immunology · Immunosuppressant

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Oncology · Early Detection

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Neurology · Pediatric Neurosurgery

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Immunology · Immunodeficiency

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Cell Therapy

Competitive landscape report

2 evidence

Updated Jul 12, 2026

Neurology · Friedreich's Ataxia

Competitive landscape report

1 evidence

Updated Jul 12, 2026

Oncology · Antiemetic

Competitive landscape report

8 evidence

Updated Jul 11, 2026

Ophthalmology · Ocular Surface Diseases

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Dermatology · Infantile Hemangiomas

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Oncology · HPV-related cancers

Competitive landscape report

4 evidence

Updated Jul 11, 2026

Oncology · HPV-related Cancers

Competitive landscape report

4 evidence

Updated Jul 11, 2026

Infectious Disease · Antibacterial

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Dermatology · Anti-fungal

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Pediatrics · ADHD

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Mental Health · Depression

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Hematology · Hemophilia

Competitive landscape report

4 evidence

Updated Jul 11, 2026

Pulmonology · Lung Fibrosis

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Cardiovascular · Abdominal Aortic Aneurysm

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Regulatory Affairs · Drug Manufacturing

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Nephrology · Chronic Kidney Disease

Competitive landscape report

6 evidence

Updated Jul 11, 2026

Endocrinology · Reproductive Health

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Infectious Disease · Sepsis

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Oncology · Soft-Tissue Sarcoma

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Immunology · Biosimilar

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Obesity · Neuromodulation

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Hematology · Autoinflammatory Syndromes

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Rheumatology · Still's Disease

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Hematology · Multiple Myeloma

Competitive landscape report

6 evidence

Updated Jul 11, 2026

Neurology · Intracerebral Hemorrhage

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Hematology · CLL/SLL and related lymphomas

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Oncology · Bone Health

Competitive landscape report

2 evidence

Updated Jul 11, 2026

Hematology · Immune Thrombocytopenia

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Obesity · Injectable Therapy

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Sleep Disorders · Sleep-Disordered Breathing

Competitive landscape report

1 evidence

Updated Jul 11, 2026

Infection Control · Medical Devices

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Oncology · Kidney Cancer

Competitive landscape report

3 evidence

Updated Jul 10, 2026

Urology · Male Infertility

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Hepatology · Primary Biliary Cholangitis

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Cardiology · Biomarker Research

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Oncology · Malignant Mesothelioma

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Pain Management · Chronic Coccydynia

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Immunology · Lupus Nephritis

Competitive landscape report

3 evidence

Updated Jul 10, 2026

Oncology · Digital Health

Competitive landscape report

2 evidence

Updated Jul 10, 2026

Regulatory Affairs · Drug Labeling

Competitive landscape report

2 evidence

Updated Jul 10, 2026

Dermatology · Atopic Dermatitis

Competitive landscape report

11 evidence

Updated Jul 10, 2026

Pulmonology · Idiopathic Pulmonary Fibrosis

Competitive landscape report

6 evidence

Updated Jul 10, 2026

Not specified · Not specified

Competitive landscape report

3 evidence

Updated Jul 10, 2026

Oncology · HER2+ Solid Tumors

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Obstetrics · Preterm Birth

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Oncology · Photodynamic Therapy

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Hematology · Plasma-derived Products

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Hematology · Plasma-derived therapies

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Dermatology · Actinic Keratosis

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Pulmonology · Fibrosing Interstitial Lung Disease

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Hematology · Stem Cell Transplantation

Competitive landscape report

3 evidence

Updated Jul 10, 2026

Oncology · Follicular Lymphoma

Competitive landscape report

4 evidence

Updated Jul 10, 2026

Oncology · Intrahepatic Cholangiocarcinoma

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Oncology · Dendrimer-based therapy

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Oncology · Combination Therapy

Competitive landscape report

9 evidence

Updated Jul 10, 2026

Endocrinology · PCOS

Competitive landscape report

2 evidence

Updated Jul 10, 2026

Infectious Disease · Respiratory Tract Infections

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Infectious Disease · Malaria

Competitive landscape report

2 evidence

Updated Jul 10, 2026

Hematology · Leukemia

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Immunology · Myositis

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Gastroenterology · Enzyme Replacement Therapy

Competitive landscape report

1 evidence

Updated Jul 10, 2026

Neurology · Traumatic Brain Injury

Competitive landscape report

2 evidence

Updated Jul 10, 2026

Cardiovascular · Monoclonal Antibody

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · CDK4/6 Inhibitor

Competitive landscape report

6 evidence

Updated Jul 9, 2026

Diabetes · Combination Therapy

Competitive landscape report

2 evidence

Updated Jul 9, 2026

Anesthesia · Opioid

Competitive landscape report

3 evidence

Updated Jul 9, 2026

Cardiology · Antiarrhythmic

Competitive landscape report

3 evidence

Updated Jul 9, 2026

Immunology · Complement Inhibition

Competitive landscape report

4 evidence

Updated Jul 9, 2026

Oncology · Pharmacokinetics

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Hepatology · Cirrhosis

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · Gastric Cancer

Competitive landscape report

7 evidence

Updated Jul 9, 2026

Neurology · Muscular Dystrophy

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Ophthalmology · Intraocular Lens

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Dermatology · Topical Steroid

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Hematology · Antifibrinolytic

Competitive landscape report

2 evidence

Updated Jul 9, 2026

Metabolic Disorders · Levocarnitine

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Urology · 5-alpha reductase inhibitor

Competitive landscape report

7 evidence

Updated Jul 9, 2026

Urology · 5-Alpha Reductase Inhibitor

Competitive landscape report

7 evidence

Updated Jul 9, 2026

Hematology · Blood Transfusion

Competitive landscape report

2 evidence

Updated Jul 9, 2026

Infectious Diseases · Tuberculosis

Competitive landscape report

3 evidence

Updated Jul 9, 2026

Oncology · Familial Adenomatous Polyposis

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Addiction · Neuromodulation

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Infectious Disease · Coronavirus

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Mental Health · PTSD

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · Pancreatic Cancer

Competitive landscape report

12 evidence

Updated Jul 9, 2026

Oncology · Oncolytic Virus Therapy

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Endocrinology · GLP-1 Agonist

Competitive landscape report

3 evidence

Updated Jul 9, 2026

Oncology · Cancer Care

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · Head and Neck Cancer

Competitive landscape report

9 evidence

Updated Jul 9, 2026

Orthopedics · Femur Fractures

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Cardiology · Transcatheter Aortic Valve Replacement

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Cardiology · ATTR-CM

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Rare Diseases · Various

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · IL-1 Inhibition

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Immunology · Autoinflammatory Disorders

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Oncology · Gastroesophageal Cancer

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Cardiology · Anticoagulation

Competitive landscape report

2 evidence

Updated Jul 9, 2026

Pediatrics · Tracheoesophageal Fistula

Competitive landscape report

1 evidence

Updated Jul 9, 2026

Ophthalmology · Anti-VEGF

Competitive landscape report

2 evidence

Updated Jul 9, 2026

Hepatology · Ascites

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Hematology · Anticoagulant

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Dermatology · JAK Inhibitor

Competitive landscape report

4 evidence

Updated Jul 8, 2026

Dermatology · Topical Anti-inflammatory

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Gastroenterology · Constipation

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Psychiatry · ADHD

Competitive landscape report

2 evidence

Updated Jul 8, 2026

Mental Health · Digital Therapeutics

Competitive landscape report

2 evidence

Updated Jul 8, 2026

Hematology · Sickle Cell Disease

Competitive landscape report

3 evidence

Updated Jul 8, 2026

Contraception · Hormonal

Competitive landscape report

2 evidence

Updated Jul 8, 2026

Dermatology · Acne

Competitive landscape report

9 evidence

Updated Jul 8, 2026

Infectious Disease · Respiratory Syncytial Virus

Competitive landscape report

6 evidence

Updated Jul 8, 2026

Genetic Disorders · Mucopolysaccharidosis

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Oncology · CD30-positive Lymphoma

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Gastroenterology · Pancreatic Disorders

Competitive landscape report

2 evidence

Updated Jul 8, 2026

Oncology · TIL Therapy

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Diabetes · Oral Hypoglycemics

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Infectious Disease · Clostridioides Difficile Infection

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Hematology · Systemic AL Amyloidosis

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Nephrology · Immunoglobulin A Nephropathy

Competitive landscape report

2 evidence

Updated Jul 8, 2026

Oncology · Esophageal Squamous Cell Carcinoma

Competitive landscape report

3 evidence

Updated Jul 8, 2026

Oncology · Pediatric Hematology

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Cardiovascular · Statin

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Oncology · FLT3 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Oncology · Biologic Therapy

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Nephrology · Dialysis

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Oncology · Radioactive Drug Therapy

Competitive landscape report

1 evidence

Updated Jul 8, 2026

Infectious Disease · Nontuberculous Mycobacterial Infections

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Anesthesiology · Postoperative Nausea and Vomiting

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Cardiovascular · Cholesterol Management

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Oncology · Meningioma

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Oncology · Imaging Biomarker

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Oncology · Esophageal Cancer

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Oncology · Hematologic Malignancies and Solid Tumors

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Otolaryngology · Voice Disorders

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Respiratory · Cough and Cold

Competitive landscape report

3 evidence

Updated Jul 7, 2026

Endocrinology · Type 2 Diabetes

Competitive landscape report

9 evidence

Updated Jul 7, 2026

Analgesia · Postoperative Pain

Competitive landscape report

2 evidence

Updated Jul 7, 2026

Oncology · EGFR-targeted therapies

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Hematology · Myelodysplastic Syndromes

Competitive landscape report

3 evidence

Updated Jul 7, 2026

Oncology · Mantle Cell Lymphoma

Competitive landscape report

2 evidence

Updated Jul 7, 2026

Cardiovascular Disease · Pneumonia

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Gastroenterology · Crohn's Disease

Competitive landscape report

4 evidence

Updated Jul 7, 2026

Oncology · HCC

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Endocrinology · Primary Aldosteronism

Competitive landscape report

2 evidence

Updated Jul 7, 2026

Infectious Disease · Antiviral

Competitive landscape report

16 evidence

Updated Jul 7, 2026

Oncology · Osteosarcoma

Competitive landscape report

3 evidence

Updated Jul 7, 2026

Oncology · Endometrial Cancer

Competitive landscape report

2 evidence

Updated Jul 7, 2026

Neurology · Inclusion Body Myositis

Competitive landscape report

1 evidence

Updated Jul 7, 2026

Anesthesia · Pain Management

Competitive landscape report

2 evidence

Updated Jul 6, 2026

Rheumatology · Small Molecule

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Oncology · Immunomodulator

Competitive landscape report

8 evidence

Updated Jul 6, 2026

Cardiovascular · Peripheral Arterial Disease

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Oncology · HIV-related Malignancies

Competitive landscape report

1 evidence

Updated Jul 6, 2026

General Medicine · Injectable

Competitive landscape report

2 evidence

Updated Jul 6, 2026

Emergency Medicine · Data Analytics

Competitive landscape report

2 evidence

Updated Jul 6, 2026

Ophthalmology · Neovascular Age-related Macular Degeneration

Competitive landscape report

3 evidence

Updated Jul 6, 2026

Ophthalmology · Neovascular Age-Related Macular Degeneration

Competitive landscape report

3 evidence

Updated Jul 6, 2026

Oncology · DNA Repair Inhibition

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Neurology · SLC6A1-NDD

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Immunology · Inflammatory Disorders

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Nephrology · Kidney Transplant

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Obstetrics · AI Decision Support

Competitive landscape report

2 evidence

Updated Jul 6, 2026

Oncology · Pediatric Neoplasms

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Rheumatology · Monoclonal Antibody

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Hematology · Acute Promyelocytic Leukemia

Competitive landscape report

1 evidence

Updated Jul 6, 2026

Endocrinology · Hypophosphatemia

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · HER2 Inhibitor

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Hematology · CD123-targeted therapy

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Addiction · Stimulant Use Disorder

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Addiction · Psilocybin

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Mental Health · Anxiety Disorders

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Pediatrics · ECMO

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · NRAS-mutant Melanoma

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Hematology · Chronic Myelomonocytic Leukemia

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Immunology · IL-4/IL-13

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Neurology · Autoimmune Diseases

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Cardiovascular · Aortic Dissection

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Neurology · Aphasia

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Sleep Disorders · Herbal Medicine

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Dermatology · Transdermal Delivery

Competitive landscape report

2 evidence

Updated Jul 5, 2026

Oncology · Pediatric

Competitive landscape report

8 evidence

Updated Jul 5, 2026

Oncology · Pediatric Cancer

Competitive landscape report

4 evidence

Updated Jul 5, 2026

Oncology · Pediatric Cancers

Competitive landscape report

2 evidence

Updated Jul 5, 2026

Genetics · Familial Mediterranean Fever

Competitive landscape report

2 evidence

Updated Jul 5, 2026

Nephrology · Vasopressin Antagonist

Competitive landscape report

2 evidence

Updated Jul 5, 2026

Oncology · Thyroid Cancer

Competitive landscape report

7 evidence

Updated Jul 5, 2026

Women's Health · Hormonal Therapy

Competitive landscape report

3 evidence

Updated Jul 5, 2026

Surgery · Thoracic

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · T Cell Non-Hodgkin Lymphoma

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Infectious Disease · Urinary Tract Infections

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · CAR T-cell Therapy

Competitive landscape report

5 evidence

Updated Jul 5, 2026

Ophthalmology · Diagnostic Imaging

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · Urothelial Carcinoma

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Reproductive Health · Assisted Reproductive Technology

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Cardiovascular Disease · Observational Study

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Oncology · Androgen Receptor Inhibitor

Competitive landscape report

2 evidence

Updated Jul 5, 2026

Autoimmune · Type 1 Diabetes

Competitive landscape report

1 evidence

Updated Jul 5, 2026

Immunology · IL-17

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Neurology · Psychotropic Agents

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Oncology · Surgical Robotics

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Pulmonary Hypertension · Rare Disease

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Neurology · Bipolar Disorder

Competitive landscape report

3 evidence

Updated Jul 4, 2026

Psychiatry · Borderline Personality Disorder

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Cardiovascular · Peripheral Artery Disease

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Not specified

Competitive landscape report

30 evidence

Updated Jul 4, 2026

Gastroenterology · Laxative

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Sleep Disorders · Melatonin Receptor Agonist

Competitive landscape report

4 evidence

Updated Jul 4, 2026

Aging · Metformin

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Addiction · Opioid Dependence

Competitive landscape report

2 evidence

Updated Jul 4, 2026

CNS · Cough Suppressant

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Metabolic Disorders · Urea Cycle Disorder

Competitive landscape report

5 evidence

Updated Jul 4, 2026

Metabolic Disorders · Urea Cycle Disorders

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Oncology · Liver Cancer

Competitive landscape report

4 evidence

Updated Jul 4, 2026

Hematology · Paroxysmal Nocturnal Hemoglobinuria

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Hematology · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Oncology · CAR T Cell Therapy

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Oncology · HPV Vaccine

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Cardiology · Dyslipidemia

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Addiction · Opioid Use Disorder

Competitive landscape report

2 evidence

Updated Jul 4, 2026

Hepatology · GLP-1 Agonist

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Endocrinology · Testosterone Deficiency

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Oncology · Gene Regulation

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Infectious Disease · Antibiotic Resistance

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Oncology · Biosimilar

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Hematology · IDH Inhibition

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Dermatology · Vascular Tumors

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Neurology · Imaging Techniques

Competitive landscape report

1 evidence

Updated Jul 4, 2026

Neurology · Stroke Recovery

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Neurology · Imaging Agent

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Neurology · Anesthesia

Competitive landscape report

2 evidence

Updated Jul 3, 2026

Cardiology · Peripheral Arterial Disease

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Oncology · Epidemiology

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Respiratory · Chronic Respiratory Disease

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Diabetes · Continuous Glucose Monitoring

Competitive landscape report

3 evidence

Updated Jul 3, 2026

Women's Health · Hormone Therapy

Competitive landscape report

2 evidence

Updated Jul 3, 2026

Nutraceuticals · Vitamin D

Competitive landscape report

2 evidence

Updated Jul 3, 2026

Hepatology · Rare Disease

Competitive landscape report

3 evidence

Updated Jul 3, 2026

Veterinary Medicine · Allergy

Competitive landscape report

2 evidence

Updated Jul 3, 2026

Oncology · Chemotherapy

Competitive landscape report

32 evidence

Updated Jul 3, 2026

Diabetes · Insulin

Competitive landscape report

3 evidence

Updated Jul 3, 2026

Diabetes · Insulin Delivery

Competitive landscape report

2 evidence

Updated Jul 3, 2026

Gastroenterology · Antidiarrheal

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Cardiology · Heart Pump

Competitive landscape report

3 evidence

Updated Jul 3, 2026

Neurology · Headache

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Oncology · BRAF-Mutant Melanoma

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Immunology · IL-23

Competitive landscape report

5 evidence

Updated Jul 3, 2026

Oncology · Hormonal Therapy

Competitive landscape report

17 evidence

Updated Jul 3, 2026

Oncology · HER2-positive Esophagogastric Adenocarcinoma

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Gastroenterology · Microbiota Therapy

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Oncology · Gastrointestinal Stromal Tumor

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Oncology · B Acute Lymphoblastic Leukemia

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Dermatology · Cold Sores

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Oncology · Breast Cancer

Competitive landscape report

51 evidence

Updated Jul 3, 2026

Hematology · Telomerase Inhibitor

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Neurology · Progressive Supranuclear Palsy and Dementia

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Cardiology · Heart Transplantation

Competitive landscape report

1 evidence

Updated Jul 3, 2026

Cardiology · Diabetes

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Oncology · GI Cancers

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Cardiology · Imaging

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Hepatology · Sepsis-induced liver injury

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Oncology · B-cell Acute Lymphoblastic Leukemia (B-ALL)

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Infectious Disease · Antibiotic

Competitive landscape report

37 evidence

Updated Jul 2, 2026

Pediatrics · Pain Management

Competitive landscape report

3 evidence

Updated Jul 2, 2026

Hematology · Rare Blood Disorders

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Musculoskeletal · Osteoarthritis

Competitive landscape report

9 evidence

Updated Jul 2, 2026

Cardiology · Rehabilitation

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Surgery · Medical Devices

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Sleep Medicine · Obstructive Sleep Apnea

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Oncology · Lymphoma

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Cardiovascular · Aneurysm

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Hematology · Myeloproliferative Neoplasms

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Dermatology · Keloids

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Pediatrics · Obesity

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Oncology · RNA Modifications

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Hematology · Gene Therapy

Competitive landscape report

2 evidence

Updated Jul 2, 2026

Oncology · KRAS G12C NSCLC

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Oncology · KRAS G12C Non-Small Cell Lung Cancer

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Neurology · Tinnitus

Competitive landscape report

1 evidence

Updated Jul 2, 2026

Infectious Disease · HIV

Competitive landscape report

23 evidence

Updated Jul 1, 2026

Oncology · Targeted Therapy

Competitive landscape report

4 evidence

Updated Jul 1, 2026

Ophthalmology · Diabetic Retinopathy

Competitive landscape report

4 evidence

Updated Jul 1, 2026

Infectious Disease · Tuberculosis

Competitive landscape report

8 evidence

Updated Jul 1, 2026

Hematology · Thrombocytopenia

Competitive landscape report

4 evidence

Updated Jul 1, 2026

Anesthesia · Local Anesthetic

Competitive landscape report

5 evidence

Updated Jul 1, 2026

Ophthalmology · Atropine

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Hematology · Chronic Myeloid Leukemia

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Neuroscience · Schizophrenia

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Hematology · Iron Deficiency Anemia

Competitive landscape report

4 evidence

Updated Jul 1, 2026

Respiratory · Wheezing Diseases

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Psychiatry · SNRI

Competitive landscape report

2 evidence

Updated Jul 1, 2026

Obstetrics · Corticosteroids

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Psychiatry · Disruptive Mood Dysregulation Disorder

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Anxiety · Non-Pharmacological Intervention

Competitive landscape report

2 evidence

Updated Jul 1, 2026

Infectious Disease · Influenza

Competitive landscape report

8 evidence

Updated Jul 1, 2026

Immunology · Hereditary Angioedema

Competitive landscape report

3 evidence

Updated Jul 1, 2026

Oncology · Immune Checkpoint Inhibitors

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Cardiology · Gene Therapy

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Oncology · Advanced Care Planning

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Oncology · Triple-Negative Breast Cancer

Competitive landscape report

9 evidence

Updated Jul 1, 2026

Urology · Kidney Stones

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Cardiology · Acute Cardiovascular Disease

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Immunology · Corticosteroid

Competitive landscape report

7 evidence

Updated Jul 1, 2026

Dermatology · Antifungal

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Dermatology · Topical Immunomodulator

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Dermatology · Topical corticosteroid

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Hematology · Immunotherapy

Competitive landscape report

2 evidence

Updated Jul 1, 2026

Immunology · Autoimmune Disease

Competitive landscape report

2 evidence

Updated Jul 1, 2026

Immunology · Autoimmune Diseases

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Cardiovascular · Rehabilitation

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Oncology · Colon Cancer

Competitive landscape report

2 evidence

Updated Jul 1, 2026

Otolaryngology · Meniere's Disease

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Cardiology · Interventional Devices

Competitive landscape report

1 evidence

Updated Jul 1, 2026

Neurology · CGRP Inhibitor

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Oncology · AML

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Oncology · Viral Immunotherapy

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Nephrology · Diabetic Kidney Disease

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Oncology · Pediatric Brain Tumors

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Endocrinology · Graves' Disease

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Rare Diseases · Cystinosis

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Oncology · Solid Tumors

Competitive landscape report

13 evidence

Updated Jun 30, 2026

Addiction · Substance Use Disorders

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Psychiatry · Stress and Anxiety

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Immunology · Rare Disease

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pulmonology · Cystic Fibrosis

Competitive landscape report

4 evidence

Updated Jun 30, 2026

Hematology · Thrombotic Microangiopathy

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Psychiatry · Eating Disorders

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Cardiology · Beta-blocker

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Neurology · RNA-targeted therapy

Competitive landscape report

3 evidence

Updated Jun 30, 2026

Reproductive Health · Male Infertility

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pain Management · OTC

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pediatrics · Respiratory Disease

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pediatrics · Medical Devices

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pharmaceuticals · Compounding

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Pulmonology · Interstitial Lung Disease

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Oncology · Antibody-Drug Conjugate

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Cardiovascular · Omega-3 Fatty Acids

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Endocrinology · Acromegaly

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Endocrinology · Hormonal Therapies

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Gastroenterology · Barrett's Esophagus

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Immunology · Gene Therapy

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Hematology · Myelodysplastic Syndromes and Acute Myeloid Leukemia

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Oncology · Renal Cell Carcinoma

Competitive landscape report

7 evidence

Updated Jun 30, 2026

Ophthalmology · Autoimmune Disease

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Ophthalmology · Thyroid Eye Disease

Competitive landscape report

2 evidence

Updated Jun 30, 2026

Infectious Disease · Leishmaniasis

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Neurology · Migraine

Competitive landscape report

12 evidence

Updated Jun 30, 2026

Cardiovascular · Antiplatelet

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Pain Management · Botulinum Toxin

Competitive landscape report

1 evidence

Updated Jun 30, 2026

Neurology · Genetic Disorders

Competitive landscape report

3 evidence

Updated Jun 30, 2026

Surgery · Gynecology

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Urology · Stress Urinary Incontinence

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Dermatology · Skin Damage

Competitive landscape report

2 evidence

Updated Jun 29, 2026

Hepatology · NASH/MASH

Competitive landscape report

3 evidence

Updated Jun 29, 2026

Cardiology · Heart Pump Devices

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Psychiatry · Postpartum Depression

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Neurology · Cerebral Palsy and Muscular Dystrophy

Competitive landscape report

2 evidence

Updated Jun 29, 2026

Cardiovascular · ACE Inhibitor

Competitive landscape report

4 evidence

Updated Jun 29, 2026

Genomics · Sequencing Technology

Competitive landscape report

2 evidence

Updated Jun 29, 2026

Oncology · Genomics

Competitive landscape report

2 evidence

Updated Jun 29, 2026

Urology · Antimicrobial

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Neurology · CADASIL

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Urology · Neurogenic Bladder Overactivity

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Pain Management · Opioid Combination

Competitive landscape report

18 evidence

Updated Jun 29, 2026

Obesity · Surgical Intervention

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Nephrology · Hemodialysis

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Oncology · Rare Genitourinary Tumors

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Urology · BPH

Competitive landscape report

3 evidence

Updated Jun 29, 2026

Otolaryngology · Cochlear Implant

Competitive landscape report

2 evidence

Updated Jun 29, 2026

Urology · Kidney Stone Disease

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Addiction Medicine · Opioid Use Disorder

Competitive landscape report

5 evidence

Updated Jun 29, 2026

Dentistry · Periodontal Disease

Competitive landscape report

1 evidence

Updated Jun 29, 2026

Infectious Disease · Hepatitis B

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Cardiology · Lipid Management

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Respiratory · Severe Pneumonia

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Pain Management · Opioids

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Cardiology · Bradyarrhythmias

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Immunology · Transplant Rejection

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Oncology · Non-small Cell Lung Cancer

Competitive landscape report

4 evidence

Updated Jun 28, 2026

Oncology · Non-Small Cell Lung Cancer

Competitive landscape report

4 evidence

Updated Jun 28, 2026

Neurology · Carpal Tunnel Syndrome

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Neurology · Diagnostic Imaging

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Cardiology · Hypertension

Competitive landscape report

4 evidence

Updated Jun 28, 2026

Metabolic Disorders · Gut Microbiome

Competitive landscape report

2 evidence

Updated Jun 28, 2026

Pain Management · Opioid

Competitive landscape report

116 evidence

Updated Jun 28, 2026

Neurology · Cannabinoid

Competitive landscape report

4 evidence

Updated Jun 28, 2026

Neurology · Cannabinoids

Competitive landscape report

3 evidence

Updated Jun 28, 2026

Urology · Overactive Bladder

Competitive landscape report

3 evidence

Updated Jun 28, 2026

Neurology · Painful Diabetic Neuropathy

Competitive landscape report

2 evidence

Updated Jun 28, 2026

Various · Pharmaceuticals

Competitive landscape report

2 evidence

Updated Jun 28, 2026

Infection Control · Antiseptic

Competitive landscape report

2 evidence

Updated Jun 28, 2026

Oncology · Bladder Cancer

Competitive landscape report

13 evidence

Updated Jun 28, 2026

Endocrinology · Obesity

Competitive landscape report

9 evidence

Updated Jun 28, 2026

Oncology · Anal Cancer

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Oncology · Small-Molecule Therapeutics

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Neurology · Addiction

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Ophthalmology · Diabetic Macular Oedema

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Pain Management · Combination Analgesic

Competitive landscape report

5 evidence

Updated Jun 28, 2026

Pain Management · Combination Analgesics

Competitive landscape report

3 evidence

Updated Jun 28, 2026

Addiction · GLP-1 Receptor Agonist

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Oncology · Head and Neck Cancer / Prostate Cancer

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Obesity · Behavioral Intervention

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Infectious Disease · Viral Infections

Competitive landscape report

1 evidence

Updated Jun 28, 2026

Cardiology · Fabry Disease

Competitive landscape report

2 evidence

Updated Jun 27, 2026

Cardiology · Stenting

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Oncology · Cancer Vaccines

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Oncology · Biomarker Discovery

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Oncology · BRAF/MEK Inhibitors

Competitive landscape report

2 evidence

Updated Jun 27, 2026

Oncology · Oral Cancer

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Cardiology · Infective Endocarditis

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Hepatology · Chronic Hepatitis D

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Ophthalmology · Autoimmune Dry Eye Disease

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Neurology · Multiple Sclerosis

Competitive landscape report

15 evidence

Updated Jun 27, 2026

Bone Health · Osteoporosis

Competitive landscape report

2 evidence

Updated Jun 27, 2026

Rheumatology · Fibromyalgia

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Gastroenterology · Chronic Anal Fissure

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Cardiology · Endothelin Receptor Antagonist

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Endocrinology · Adrenal Insufficiency

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Oncology · Skin Melanoma

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Ophthalmology · Gene Therapy

Competitive landscape report

3 evidence

Updated Jun 27, 2026

Women's Health · Contraceptive

Competitive landscape report

7 evidence

Updated Jun 27, 2026

Oncology · Bone Cancer

Competitive landscape report

2 evidence

Updated Jun 27, 2026

Orthopedics · Osteoarthritis

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Infectious Disease · Antitubercular

Competitive landscape report

1 evidence

Updated Jun 27, 2026

Addiction · Alcohol Use Disorder

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Cardiology · Coronary Artery Disease

Competitive landscape report

2 evidence

Updated Jun 26, 2026

Gastroenterology · H. pylori Infection

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Oncology · Gene Therapy

Competitive landscape report

3 evidence

Updated Jun 26, 2026

Neurology · MS

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Neurology · GRIN-related Neurodevelopmental Disorder

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Obesity · GLP-1

Competitive landscape report

14 evidence

Updated Jun 26, 2026

Obesity · GLP-1 Agonist

Competitive landscape report

4 evidence

Updated Jun 26, 2026

Obesity · GLP-1 Agonists

Competitive landscape report

2 evidence

Updated Jun 26, 2026

Oncology · Radiation Therapy

Competitive landscape report

3 evidence

Updated Jun 26, 2026

Oncology · Brain Cancer

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Pulmonology · Pulmonary Fibrosis

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Neurology · Neonatal Hypoxic-Ischemic Encephalopathy

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Gastroenterology · Acupuncture

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Genetic Disorders · Enzyme Replacement Therapy

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Hematology · Mastocytosis

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Cardiology · Anticoagulants

Competitive landscape report

1 evidence

Updated Jun 26, 2026

Cardiology · Delirium Prevention

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Anesthesia · Ketamine

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Endocrinology · Hypertriglyceridemia

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Allergy · Anaphylaxis

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Endocrinology · GLP-1

Competitive landscape report

7 evidence

Updated Jun 25, 2026

Endocrinology · GLP-1/GIP Agonist

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Nephrology · SGLT2 Inhibitor

Competitive landscape report

4 evidence

Updated Jun 25, 2026

Nephrology · SGLT2 Inhibitors

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Neurology · Sleep-Wake Disorders

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Oncology · Colorectal Cancer

Competitive landscape report

34 evidence

Updated Jun 25, 2026

Infectious Disease · COVID-19

Competitive landscape report

15 evidence

Updated Jun 25, 2026

Immunology · Vaccine Development

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Anesthesiology · Pain Management

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Cardiology · Aortic Aneurysm

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Oncology · HPV Vaccination

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Oncology · Gynecologic Cancer

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Pain Management · Chronic Non-Cancer Pain

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Endocrinology · Type II Diabetes

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Women's Health · Endometriosis

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Nephrology · Acute Kidney Injury

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Oncology · Acute Myeloid Leukemia

Competitive landscape report

4 evidence

Updated Jun 25, 2026

Oncology · Fertility Preservation

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Infectious Disease · Pneumococcal Vaccination

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Oncology · PARP Inhibitor

Competitive landscape report

2 evidence

Updated Jun 25, 2026

Oncology · PARP Inhibitor and PI3K Inhibitor

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Anesthesia · Regional Anesthesia

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Hematology · CAR-T

Competitive landscape report

1 evidence

Updated Jun 25, 2026

Hematology · CLL/SLL

Competitive landscape report

6 evidence

Updated Jun 25, 2026

Immunology · Lupus and Rheumatoid Arthritis

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Addiction · Alcohol Dependence

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Ophthalmology · Eye Drops

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Infectious Disease · Respiratory Syncytial Virus (RSV)

Competitive landscape report

4 evidence

Updated Jun 24, 2026

Oncology · Solid Tumors and CNS Tumors

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Oncology · Burkitt Lymphoma

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Neurology · Stroke

Competitive landscape report

7 evidence

Updated Jun 24, 2026

Neurology · Stroke Rehabilitation

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Reproductive Health · GnRH Antagonist

Competitive landscape report

3 evidence

Updated Jun 24, 2026

Psychiatry · Antidepressant

Competitive landscape report

5 evidence

Updated Jun 24, 2026

Surgery · Infection Prevention

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Pain Management · NSAID

Competitive landscape report

7 evidence

Updated Jun 24, 2026

Substance Use Disorder · Opioid Use Disorder

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Cardiovascular Disease · Nutritional Assessment

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Infectious Disease · Syphilis

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Neurology · Sleep Disorders

Competitive landscape report

3 evidence

Updated Jun 24, 2026

Cardiology · LDL-C lowering

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Cardiology · LDL-C Lowering

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Hematology · CLL

Competitive landscape report

9 evidence

Updated Jun 24, 2026

Neurology · Multifocal Motor Neuropathy

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Hematology · Thalassemia

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Oncology · Surgical Care

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Oncology · Diagnostics and Multiple Sclerosis · BTK Inhibitor

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Neurology · Muscle Relaxant

Competitive landscape report

2 evidence

Updated Jun 24, 2026

Oncology · Thyroid Carcinoma

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Allergy · Antihistamine

Competitive landscape report

9 evidence

Updated Jun 24, 2026

Hematology · Acute Myeloid Leukemia

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Cardiovascular · Pulmonary Arterial Hypertension

Competitive landscape report

1 evidence

Updated Jun 24, 2026

Neurology · Wakefulness-promoting agent

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Sleep Disorders · Obstructive Sleep Apnea

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Genetics · Gene Therapy

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Oncology · Uveal Melanoma

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Endocrinology · Hypercalcemia

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Endocrinology · Gestational Diabetes

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Oncology · Bispecific T-cell Engager

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Neurology · Wakefulness Promoting Agent

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Endocrinology · Vitamin D Analog

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Hematology · Spleen Tyrosine Kinase Inhibitor

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Gastroenterology · Regenerative Therapy

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Oncology · FGFR Inhibitor

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Endocrinology · Dopamine Agonist

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Gastroenterology · Proton Pump Inhibitor

Competitive landscape report

7 evidence

Updated Jun 23, 2026

Nephrology · Monoclonal Antibody

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Cardiovascular · Beta-blocker

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Cardiovascular · Gene Editing

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Oncology · ADC

Competitive landscape report

14 evidence

Updated Jun 23, 2026

Mental Health · Behavioral Interventions

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Cardiology · Electrolyte Replacement

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Pain Management · Chronic Low Back Pain

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Critical Care · Catheterization

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Pain Management · Pediatric

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Pain Management · Analgesic

Competitive landscape report

15 evidence

Updated Jun 23, 2026

Pain Management · Analgesics

Competitive landscape report

5 evidence

Updated Jun 23, 2026

Immunology · Monoclonal Antibodies

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Biologics · Drug Delivery

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Obesity · GLP-1 Receptor Agonist

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Gastroenterology · Ulcerative Colitis

Competitive landscape report

12 evidence

Updated Jun 23, 2026

Hepatology · Chronic Liver Disease

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Orthopedics · Regenerative Medicine

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Cardiology · Pulmonary Arterial Hypertension

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Women's Health · Uterine Fibroids

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Neurology · Pediatric Demyelinating Diseases

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Oncology · Ewing Sarcoma

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Immunology · JAK Inhibitor

Competitive landscape report

19 evidence

Updated Jun 23, 2026

Imaging · Contrast Agent

Competitive landscape report

6 evidence

Updated Jun 23, 2026

Genetic Disorders · Congenital Disorders of Glycosylation

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Endocrinology · Type I Diabetes

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Respiratory · Bronchial Challenge Test

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Psychiatry · Antipsychotic

Competitive landscape report

19 evidence

Updated Jun 23, 2026

General · AI in Drug Development

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Endocrinology · Hypertension

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Neurology · Parkinson's Disease

Competitive landscape report

22 evidence

Updated Jun 23, 2026

Oncology · Small Molecule

Competitive landscape report

27 evidence

Updated Jun 23, 2026

Ophthalmology · Glaucoma

Competitive landscape report

16 evidence

Updated Jun 23, 2026

Respiratory · Asthma

Competitive landscape report

15 evidence

Updated Jun 23, 2026

Neurology · Infectious Disease

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Hepatology · Vasopressor

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Cardiovascular · Anticoagulant

Competitive landscape report

20 evidence

Updated Jun 23, 2026

Hematology · JAK Inhibitor

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Neurology · Pain Management

Competitive landscape report

11 evidence

Updated Jun 23, 2026

Urology · Pain Management

Competitive landscape report

12 evidence

Updated Jun 23, 2026

Neuroscience · Alcohol Use Disorder

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Anesthesia · Neuromuscular Blocker

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Psychiatry · PTSD

Competitive landscape report

5 evidence

Updated Jun 23, 2026

Cardiovascular · Medical Devices

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Ophthalmology · Diagnostic Agent

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Diabetes · SGLT2 Inhibitor

Competitive landscape report

12 evidence

Updated Jun 23, 2026

Pulmonary Embolism · Interventional Procedure

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Bone Health · Bisphosphonate

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Osteoporosis · Bisphosphonate

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Infectious Disease · Vaccine

Competitive landscape report

18 evidence

Updated Jun 23, 2026

Obstetrics · Gynecological Procedures

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Cardiology · Transcatheter Aortic Valve Implantation

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Infectious Disease · COVID-19 Vaccine

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Obesity · Small Molecule

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Oncology · Chemotherapy-Induced Peripheral Neuropathy

Competitive landscape report

2 evidence

Updated Jun 23, 2026

Oncology · Immuno-Oncology

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Cardiovascular · ACS

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Otolaryngology · Chronic Rhinosinusitis with Nasal Polyps

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Dermatology · Aesthetic Medicine

Competitive landscape report

4 evidence

Updated Jun 23, 2026

Vascular · Varicose Veins

Competitive landscape report

3 evidence

Updated Jun 23, 2026

Oncology · HER2-positive Gastric Cancer

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Dermatology · Skin Hydration

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Obesity · Oral Tablet

Competitive landscape report

1 evidence

Updated Jun 23, 2026

Infectious Disease · Antiparasitic

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Hematology · Monoclonal Antibody

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Nephrology · Pruritus

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Oncology · Data Collection

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Hematology · Acute Leukemia / Myelodysplastic Syndrome

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Respiratory · COPD

Competitive landscape report

13 evidence

Updated Jun 22, 2026

Neurology · Gaucher Disease and Parkinsonism

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Hepatology · Alcohol Use Disorder

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Oncology · T-cell Acute Lymphoblastic Leukemia

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Oncology · T-Cell Acute Lymphoblastic Leukemia

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Oncology · Tenosynovial Giant Cell Tumor

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Respiratory · Chronic Obstructive Pulmonary Disease (COPD)

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Veterinary Medicine · Parasitic Infections

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Anesthesia · Local Anesthetics

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Respiratory · Device

Competitive landscape report

2 evidence

Updated Jun 22, 2026

Neurology · Autoimmune Disorders

Competitive landscape report

4 evidence

Updated Jun 22, 2026

Pulmonology · Oncology

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Oncology · SCLC

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Cardiology · Heart Disease

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Hematology · cGVHD

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Dermatology · Small Molecule

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Respiratory · Nasal Spray

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Gynecology · Endometriosis

Competitive landscape report

3 evidence

Updated Jun 22, 2026

Gastroenterology · AI in Diagnostics

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Anesthesia · Surgical Procedures

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Neurology · Amyotrophic Lateral Sclerosis (ALS)

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Neurology · Neuroimmune Diseases

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Cardiology · Pulmonary Hypertension

Competitive landscape report

6 evidence

Updated Jun 22, 2026

Pulmonology · Neonatal Care

Competitive landscape report

1 evidence

Updated Jun 22, 2026

Oncology · Ovarian Cancer

Competitive landscape report

8 evidence

Updated Jun 21, 2026

Immunology · IL-5

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Women's Health · Nausea and Vomiting in Pregnancy

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Infectious Disease · Antimalarial

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Cardiology · Microvascular Health

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Anesthesia · Monitoring

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Neurology · Autoimmune Disease

Competitive landscape report

3 evidence

Updated Jun 21, 2026

Oncology · DLBCL

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Neurology · Neurodevelopmental Disorders

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Hepatology · Liver Fibrosis

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Rheumatology · Psoriatic Arthritis

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Oncology · CAR-T

Competitive landscape report

7 evidence

Updated Jun 21, 2026

Respiratory · Bronchodilator

Competitive landscape report

6 evidence

Updated Jun 21, 2026

Neurology · Cough Suppressant

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Cardiology · Hypertrophic Cardiomyopathy

Competitive landscape report

2 evidence

Updated Jun 21, 2026

Neurology · Multiple System Atrophy

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Neurology · Status Epilepticus

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Respiratory · Bronchial Provocation Testing

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Neurology · CGRP Antibody

Competitive landscape report

1 evidence

Updated Jun 21, 2026

Cardiovascular · Hypercholesterolemia

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Antineoplastic

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Neurology · Duchenne Muscular Dystrophy

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · mCRC

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Gallbladder Cancer

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Cardiology · ACE Inhibitors

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Endocrinology · Polycystic Ovary Syndrome

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Immunology · Systemic Lupus Erythematosus

Competitive landscape report

7 evidence

Updated Jun 20, 2026

Diabetes · GLP-1

Competitive landscape report

4 evidence

Updated Jun 20, 2026

Oncology · Melanoma

Competitive landscape report

16 evidence

Updated Jun 20, 2026

Cardiology · Antihypertensive

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Diabetes · SGLT2 Inhibitor and Biguanide

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Neurology · Alzheimer's Disease

Competitive landscape report

18 evidence

Updated Jun 20, 2026

Oncology · Cervical Cancer

Competitive landscape report

9 evidence

Updated Jun 20, 2026

Oncology · Lung Cancer

Competitive landscape report

9 evidence

Updated Jun 20, 2026

Anesthesia · Medical Devices

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Oncology · Diffuse Large B-Cell Lymphoma

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Dermatology · Autoimmune Disease

Competitive landscape report

3 evidence

Updated Jun 20, 2026

Hematology · Amyloidosis

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Radioconjugate

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Ophthalmology · Retinitis Pigmentosa

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Neurology · Antiepileptic

Competitive landscape report

44 evidence

Updated Jun 20, 2026

Neurology · Antiemetic

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Oncology · Hepatocellular Carcinoma

Competitive landscape report

14 evidence

Updated Jun 20, 2026

Oncology · Multiple Myeloma

Competitive landscape report

10 evidence

Updated Jun 20, 2026

Oncology · Metabolic Reprogramming

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Pediatrics · Malnutrition

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Oncology · Brain Metastases

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Cancer-related Fatigue

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Hematology · Immune Thrombocytopenic Purpura

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Surgery

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Infectious Disease · Antibiotic Prophylaxis

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Neurology · Opioid Overdose

Competitive landscape report

2 evidence

Updated Jun 20, 2026

Oncology · Medical Devices

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Oncology · Immune Checkpoint Inhibitor

Competitive landscape report

4 evidence

Updated Jun 20, 2026

Immunology · Type 1 Diabetes

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Immunology · Genetic Disorders

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Dermatology · Autoimmune Diseases

Competitive landscape report

1 evidence

Updated Jun 20, 2026

Neurology · Antihistamine

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Oncology · ALK Inhibitor

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Neurology · Opioid Use Disorder

Competitive landscape report

3 evidence

Updated Jun 19, 2026

Oncology · Skin Tumors

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Neurology · Charcot-Marie-Tooth Disease

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Cardiovascular · Vasopressor

Competitive landscape report

2 evidence

Updated Jun 19, 2026

Oncology · ULK1 Inhibition

Competitive landscape report

1 evidence

Updated Jun 19, 2026

General · Drug Development

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Genetic Disorders · Fabry Disease

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Otolaryngology · Hearing Loss

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Dermatology · Vitiligo

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Psychiatry · Pediatric Bipolar Disorder

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Oncology · NK/T-Cell Lymphoma

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Cardiology · Catheters

Competitive landscape report

2 evidence

Updated Jun 19, 2026

Pulmonary Hypertension · Biomarkers

Competitive landscape report

2 evidence

Updated Jun 19, 2026

Diabetes · Neuropathy

Competitive landscape report

2 evidence

Updated Jun 19, 2026

Oncology · Imaging

Competitive landscape report

4 evidence

Updated Jun 19, 2026

Women's Health · Menopause

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Neurology · Dysphagia

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Oncology · Non-Hodgkin Lymphoma

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Oncology · CLL

Competitive landscape report

6 evidence

Updated Jun 19, 2026

Oncology · CLL/SLL

Competitive landscape report

5 evidence

Updated Jun 19, 2026

Neurology · Rett Syndrome

Competitive landscape report

1 evidence

Updated Jun 19, 2026

Infectious Disease · Pneumococcal Vaccine

Competitive landscape report

2 evidence

Updated Jun 19, 2026

Gastroenterology · Functional Dyspepsia

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Addiction · Smoking Cessation

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Cardiology · PAH

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Infectious Disease · Bacterial Infections

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Oncology · Survivorship

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Oncology · Tyrosine Kinase Inhibitor

Competitive landscape report

8 evidence

Updated Jun 18, 2026

Oncology · Patient Reported Outcomes

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Oncology · Drug Development

Competitive landscape report

3 evidence

Updated Jun 18, 2026

Cardiology · Cardiogenic Shock

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Oncology · Monoclonal Antibodies

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Obesity · Endoscopic Procedure

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Oncology · Rectal Cancer

Competitive landscape report

4 evidence

Updated Jun 18, 2026

Oncology · Sarcoma

Competitive landscape report

3 evidence

Updated Jun 18, 2026

Oncology · Biliary Tract Cancer

Competitive landscape report

2 evidence

Updated Jun 18, 2026

Women's Health · Fertility

Competitive landscape report

1 evidence

Updated Jun 18, 2026

Endocrinology · GLP-1 Agonists

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · Solid Tumors and Hematology · AML

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Dermatology · Stem Cell Therapy

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Cardiology · Device Therapy

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Infectious Disease · Cell Therapy

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · Breast Tumors

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · Neuroendocrine Tumours

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Rheumatology · Biologic

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Obesity · Pharmacotherapy

Competitive landscape report

2 evidence

Updated Jun 17, 2026

Neurology · Amyotrophic Lateral Sclerosis

Competitive landscape report

3 evidence

Updated Jun 17, 2026

Endocrinology · Type 1 Diabetes

Competitive landscape report

7 evidence

Updated Jun 17, 2026

Oncology · Prostate Cancer

Competitive landscape report

39 evidence

Updated Jun 17, 2026

Ophthalmology · Ocular Inflammation

Competitive landscape report

2 evidence

Updated Jun 17, 2026

Oncology · Pancreatic Adenocarcinoma

Competitive landscape report

2 evidence

Updated Jun 17, 2026

Oncology · Immune-Mobilizing T-cell Receptors

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Pulmonology · Pulmonary Hypertension

Competitive landscape report

3 evidence

Updated Jun 17, 2026

Oncology · HER2 Positive Endometrial Cancer

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · Small Cell Lung Cancer

Competitive landscape report

6 evidence

Updated Jun 17, 2026

Oncology · Mesothelioma

Competitive landscape report

2 evidence

Updated Jun 17, 2026

Respiratory · Chronic Cough

Competitive landscape report

2 evidence

Updated Jun 17, 2026

Oncology · Skin Cancer

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · CNS Tumors

Competitive landscape report

4 evidence

Updated Jun 17, 2026

Oncology · Cervical and Vaginal Cancer

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · BCR::ABL1 Inhibition

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Ophthalmology · Retinal Diseases

Competitive landscape report

3 evidence

Updated Jun 17, 2026

Infectious Disease · HIV-1

Competitive landscape report

1 evidence

Updated Jun 17, 2026

Oncology · Digital Pathology

Competitive landscape report

3 evidence

Updated Jun 16, 2026

Infectious Disease · Viral and Bacterial Pathogens

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Obesity · GLP-1/GIP Receptor Agonist and Amylin Analog

Competitive landscape report

3 evidence

Updated Jun 16, 2026

Obesity · Oral GLP-1 receptor agonist

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Oncology · NRG1 Fusion-Positive Cholangiocarcinoma

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Cardiovascular · PCSK9 Inhibition

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Obesity · Peptide Therapy

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Oncology · Immunotherapy

Competitive landscape report

38 evidence

Updated Jun 16, 2026

Oncology · KRAS G12C Inhibitor

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Hematology · Hemophilia A/B

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Hematology · BTK Degrader

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Oncology · Hormone Receptor-positive Breast Cancer

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Oncology · RET fusion-positive lung cancer

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Oncology · NSCLC

Competitive landscape report

38 evidence

Updated Jun 16, 2026

Obesity · Triple Agonist

Competitive landscape report

2 evidence

Updated Jun 16, 2026

Oncology · ER-positive Breast Cancer

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Oncology · B-cell Malignancies

Competitive landscape report

1 evidence

Updated Jun 16, 2026

Oncology · Bispecific Antibodies

Competitive landscape report

1 evidence

Updated Jun 15, 2026

Pulmonology · Obstructive Sleep Apnea

Competitive landscape report

3 evidence

Updated Jun 15, 2026

Oncology · EZH2 Inhibitor

Competitive landscape report

1 evidence

Updated Jun 15, 2026

Hematology · Myelofibrosis

Competitive landscape report

1 evidence

Updated Jun 14, 2026

Oncology · Oropharyngeal Cancer

Competitive landscape report

1 evidence

Updated Jun 12, 2026

Oncology · Neuroendocrine Tumors

Competitive landscape report

1 evidence

Updated Jun 12, 2026

Anesthesiology · Pediatric Surgery

Competitive landscape report

2 evidence

Updated Jun 12, 2026

Dermatology · Incontinence-Associated Dermatitis

Competitive landscape report

1 evidence

Updated Jun 12, 2026

Psychiatry · Weight Management

Competitive landscape report

1 evidence

Updated Jun 11, 2026

Infectious Disease · Fungal Infections

Competitive landscape report

3 evidence

Updated Jun 11, 2026

Infectious Disease · Cytokine Modulation

Competitive landscape report

1 evidence

Updated Jun 11, 2026

Hepatology · MASLD

Competitive landscape report

1 evidence

Updated Jun 11, 2026

Oncology · Image-Guided Therapy

Competitive landscape report

1 evidence

Updated Jun 11, 2026

Neurology · ALS

Competitive landscape report

1 evidence

Updated Jun 10, 2026

Neurology · Antipsychotic

Competitive landscape report

1 evidence

Updated Jun 9, 2026

Pain Management · Local Anesthetic

Competitive landscape report

2 evidence

Updated Jun 9, 2026

Infectious Disease · HIV and Contraception

Competitive landscape report

2 evidence

Updated Jun 8, 2026

Pulmonary Arterial Hypertension · Prostacyclin Analog

Competitive landscape report

2 evidence

Updated Jun 6, 2026

Rare Diseases · Hypophosphatasia

Competitive landscape report

2 evidence

Updated Jun 3, 2026

General · Drug Safety

Competitive landscape report

2 evidence

Updated Jun 3, 2026

Cardiology · Surgical Intervention

Competitive landscape report

1 evidence

Updated Jun 2, 2026

Oncology · HER2-positive solid tumours

Competitive landscape report

1 evidence

Updated Jun 2, 2026

Ophthalmology · Diabetic Macular Edema

Competitive landscape report

1 evidence

Updated Jun 1, 2026

Therapeutic area assessment

6 evidence

Updated Jul 20, 2026

Gastroenterology · Device

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Oncology · T-cell malignancies

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Surgery · Anesthesia

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Cardiovascular · Hypertension

Therapeutic area assessment

5 evidence

Updated Jul 20, 2026

Oncology · AKT Inhibitor

Therapeutic area assessment

3 evidence

Updated Jul 20, 2026

Oncology · MEK Inhibitor

Therapeutic area assessment

3 evidence

Updated Jul 20, 2026

Endocrinology · Rare Genetic Disorders

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Neurology · Intracranial Aneurysms

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Cardiology · Intraoperative Monitoring

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Women's Health · Mental Health

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Endocrinology · Obesity and Type 2 Diabetes

Therapeutic area assessment

2 evidence

Updated Jul 20, 2026

Rare Diseases · Urea Cycle Disorders

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Rare Diseases · Enzyme Replacement Therapy

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Pulmonary Arterial Hypertension · Oral Therapy

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Immunology · IL-6 Inhibitor

Therapeutic area assessment

3 evidence

Updated Jul 20, 2026

Orthopedics · Spine Surgery

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Endocrinology · Congenital Adrenal Hyperplasia

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Musculoskeletal · De Quervain Tenosynovitis

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Gastroenterology · Bowel Care

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Pain Management · Anesthesia

Therapeutic area assessment

6 evidence

Updated Jul 20, 2026

Oncology · B-Cell Non-Hodgkin's Lymphoma

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Hepatology · Antiviral

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Neurology · Epilepsy

Therapeutic area assessment

4 evidence

Updated Jul 20, 2026

Nephrology · Pharmacokinetics

Therapeutic area assessment

2 evidence

Updated Jul 20, 2026

Ophthalmology · AI Diagnostics

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Neurology · Acute Ischemic Stroke

Therapeutic area assessment

3 evidence

Updated Jul 20, 2026

Obstetrics · Substance Use Disorder

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Oncology · Geriatric Assessment

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Oncology · Soft Tissue Sarcoma

Therapeutic area assessment

2 evidence

Updated Jul 20, 2026

Dermatology · Autoimmune Disorders

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Diabetes · DPP-4 Inhibitor and Biguanide

Therapeutic area assessment

3 evidence

Updated Jul 20, 2026

Gastroenterology · IBS-C

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Addiction · Opioids

Therapeutic area assessment

1 evidence

Updated Jul 20, 2026

Oncology · Supportive Care

Therapeutic area assessment

18 evidence

Updated Jul 19, 2026

Neurology · Anticonvulsant

Therapeutic area assessment

11 evidence

Updated Jul 19, 2026

Neurology · ADHD

Therapeutic area assessment

8 evidence

Updated Jul 19, 2026

Oncology · Bone Metastases

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Endocrinology · Thyroid Disorders

Therapeutic area assessment

4 evidence

Updated Jul 19, 2026

Ophthalmology · Presbyopia

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Oncology · B-cell Non-Hodgkin Lymphoma

Therapeutic area assessment

3 evidence

Updated Jul 19, 2026

Oncology · B-Cell Non-Hodgkin Lymphoma

Therapeutic area assessment

3 evidence

Updated Jul 19, 2026

Neurology · Cognitive Impairment

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Cardiovascular · Beta Blocker

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Cardiology · Calcium Channel Blocker

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Cardiovascular · Calcium Channel Blocker

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Cardiovascular · Aldosterone Antagonist

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

ENT · Surgical Intervention

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Diabetes · GLP-1 Receptor Agonist

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Oncology · BTK Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Rheumatology · Osteoarthritis

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Cardiology · Cholesterol Management

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Hepatology · Metabolic Dysfunction-Associated Steatohepatitis

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Oncology · Bone Metabolism

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Gastroenterology · Linaclotide

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Cardiology · Beta-agonist

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Oncology · HER2-positive Breast Cancer

Therapeutic area assessment

5 evidence

Updated Jul 19, 2026

Respiratory · Anticholinergic

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Obstetrics · Chronic Pain Management

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Ophthalmology · Vision Impairment

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Oncology · CAR NK Cell Therapy

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Infectious Disease · Osteomyelitis

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Neurology · Developmental Language Disorder

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Pain Management · Chronic Pain

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Hematology · Vitamin K

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Reproductive Health · Hormonal Therapy

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Neurology · Schizophrenia

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Infectious Disease · HIV/HBV Co-Infection

Therapeutic area assessment

1 evidence

Updated Jul 19, 2026

Dermatology · Hidradenitis Suppurativa

Therapeutic area assessment

2 evidence

Updated Jul 19, 2026

Oncology · Oral Agent

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · Smoking Cessation

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Psychiatry · Mood Disorders

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · Glioma

Therapeutic area assessment

3 evidence

Updated Jul 18, 2026

Obesity · Nanoparticle Therapy

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · Nanomedicine

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Dermatology · Exosome Therapy

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Neurology · Spinal Cord Injury

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Neonatology · Oral Care

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Addiction · Nicotine

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Neurology · Depression

Therapeutic area assessment

9 evidence

Updated Jul 18, 2026

Immunology · IL-12/23

Therapeutic area assessment

4 evidence

Updated Jul 18, 2026

Immunology · IL-12/23 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Endocrinology · Hormonal Therapy

Therapeutic area assessment

3 evidence

Updated Jul 18, 2026

Cardiovascular · PCSK9 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Endocrinology · Diabetes

Therapeutic area assessment

8 evidence

Updated Jul 18, 2026

Endocrinology · Diabetes Insipidus

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Allergy · Food Allergy

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Urology · Bladder Pain Syndrome

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Gastroenterology · Inflammatory Bowel Disease

Therapeutic area assessment

9 evidence

Updated Jul 18, 2026

Cardiology · Hypercholesterolemia

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Infectious Disease · Antibiotic Therapy

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Cardiovascular · Dyslipidemia

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Ophthalmology · Dry Age-related Macular Degeneration

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · RET Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · EGFR Inhibitor

Therapeutic area assessment

4 evidence

Updated Jul 18, 2026

Oncology · PI3K Inhibitor

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Endocrinology · Growth Hormone Deficiency

Therapeutic area assessment

5 evidence

Updated Jul 18, 2026

Neurology · Anxiety Disorders

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Neurology · Mood Disorders

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Nephrology · Focal Segmental Glomerulosclerosis

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Hepatology · Chronic Hepatitis B

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Infectious Disease · Medical Devices

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Cardiovascular · Lipid Regulation

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Nephrology · Complement Inhibition

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Neurology · Anxiolytic

Therapeutic area assessment

2 evidence

Updated Jul 18, 2026

Oncology · PD-L1 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Immunology · TNF Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Oncology · BCL-2 Inhibitor

Therapeutic area assessment

3 evidence

Updated Jul 18, 2026

Urology · PDE5 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Psychiatry · Depression

Therapeutic area assessment

1 evidence

Updated Jul 18, 2026

Dermatology · Topical Retinoid

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Oncology · VEGF Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Respiratory · Asthma/COPD

Therapeutic area assessment

3 evidence

Updated Jul 17, 2026

Psychiatry · Mental Health

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Neurology · Imaging

Therapeutic area assessment

3 evidence

Updated Jul 17, 2026

Oncology · Radioligand Therapy

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Oncology · Lymphedema

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Cardiovascular · Atherosclerosis

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Diabetes · Drug Interaction

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Oncology · Head and Neck Squamous Cell Carcinoma

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Cardiology · Atrial Fibrillation

Therapeutic area assessment

5 evidence

Updated Jul 17, 2026

Cardiology · Atrial Fibrillation and Heart Failure

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Neuroscience · Depression

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Anesthesia · Injectable

Therapeutic area assessment

3 evidence

Updated Jul 17, 2026

Oncology · Cognitive Impairment

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Pain Management · Neuromodulation

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Gastroenterology · Drug Delivery

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Oncology · Glioblastoma

Therapeutic area assessment

12 evidence

Updated Jul 17, 2026

Oncology · PD-1 Inhibition

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Metabolism · Oral Drug Delivery

Therapeutic area assessment

1 evidence

Updated Jul 17, 2026

Oncology · CNS Lymphoma

Therapeutic area assessment

2 evidence

Updated Jul 17, 2026

Cardiology · Mineralocorticoid Receptor Antagonist

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Metabolic Disorders · Amino Acid Supplement

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Oncology · Radiopharmaceutical

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Pulmonology · Respiratory Distress

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Oncology · RAS Mutations

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Anesthesiology · Pediatric Pain Management

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Urology · Urinary Incontinence

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Ophthalmology · Dry Eye Disease

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Veterinary Medicine · Parasitology

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Oncology · Radiotherapy

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Gynecology · Endometrial Hyperplasia

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Not specified · Not applicable

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Respiratory · Ventilation

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Dermatology · Skin Disorders

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Nutritional Support · Parenteral Nutrition

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Obstetrics · Tocolytics

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Respiratory · Medical Devices

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Surgery · Pilonidal Sinus Disease

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Neurology · Botulinum Toxin

Therapeutic area assessment

3 evidence

Updated Jul 16, 2026

Oncology · Biomarkers

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Cardiology · Acute Coronary Syndrome

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Infectious Disease · Antiretroviral

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Diabetes · Oral Hypoglycemic

Therapeutic area assessment

6 evidence

Updated Jul 16, 2026

Pulmonary Hypertension · Prostacyclin Analog

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Electrolyte Imbalance · Magnesium Supplement

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Metabolic Disorders · Electrolyte Replenisher

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Cardiology · Radiopharmaceutical

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Neurology · Intracranial Hemorrhage

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Obesity · GLP-1 Receptor Agonists

Therapeutic area assessment

2 evidence

Updated Jul 16, 2026

Oncology · Rare Cancers

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Infectious Disease · Epstein-Barr Virus

Therapeutic area assessment

1 evidence

Updated Jul 16, 2026

Oncology · Brain Tumors

Therapeutic area assessment

3 evidence

Updated Jul 16, 2026

Cardiology · Diuretic

Therapeutic area assessment

3 evidence

Updated Jul 15, 2026

Oncology · mTOR Inhibitor

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Neurology · Myasthenia Gravis

Therapeutic area assessment

3 evidence

Updated Jul 15, 2026

Infectious Disease · Vaccines

Therapeutic area assessment

6 evidence

Updated Jul 15, 2026

Oncology · Immune Response

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Musculoskeletal · Knee Osteoarthritis

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Pediatrics · Neonatology

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Pain Management · Regional Anesthesia

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Rheumatology · Juvenile Idiopathic Arthritis

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Oncology · PD-1 Inhibitor

Therapeutic area assessment

11 evidence

Updated Jul 15, 2026

Oncology · Imaging Agent

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Obstetrics · Uterotonics

Therapeutic area assessment

3 evidence

Updated Jul 15, 2026

Nutritional Deficiency · Vitamin B12

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Nephrology · IgA Nephropathy

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Oncology · Chronic Lymphocytic Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Oncology · CAR-T Cell Therapy

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Oncology · HER2-positive Upper Tract Urothelial Carcinoma

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Pain Management · Medical Device

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Pain Management · Medical Devices

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Cardiology · Aortic Stenosis

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Metabolic Disorders · Electrolyte Replacement

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Infectious Disease · Antimicrobial

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Psychiatry · Major Depressive Disorder

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Neurology · Niemann-Pick Type C Disease

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Oncology · RET Fusion-Positive Tumors

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Nephrology · Autoimmune Disease

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Oncology · Neuroblastoma

Therapeutic area assessment

5 evidence

Updated Jul 15, 2026

Oncology · Tumor Metastasis

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Diabetes · Pharmacokinetics

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Pulmonology · Smoking Cessation

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Immunology · Lupus

Therapeutic area assessment

5 evidence

Updated Jul 15, 2026

Pediatrics · Cholestasis

Therapeutic area assessment

1 evidence

Updated Jul 15, 2026

Oncology · Mental Health

Therapeutic area assessment

2 evidence

Updated Jul 15, 2026

Anesthesia · Neuromuscular Blockade

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Gastroenterology · H2 Antagonist

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Smoking Cessation · Nicotine Replacement Therapy

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Endocrinology · Hormone Replacement Therapy

Therapeutic area assessment

4 evidence

Updated Jul 14, 2026

Pain Management · Acupuncture

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Neurology · PTSD

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Ophthalmology · Myopia

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Neurology · Narcolepsy

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Oncology · CDK7 Inhibition

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Infectious Diseases · Hepatitis D

Therapeutic area assessment

4 evidence

Updated Jul 14, 2026

Cardiology · Heart Failure

Therapeutic area assessment

16 evidence

Updated Jul 14, 2026

Mental Health · Psychedelics

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Oncology · Veterinary

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Immunology · Psoriasis and Autoimmune Diseases

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Oncology · BiTE

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Immunology · Autoimmune Disorders

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Oncology · Cancer Genetics

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Hepatology · Fatty Liver Disease

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Oncology · Pancreatic Ductal Adenocarcinoma

Therapeutic area assessment

3 evidence

Updated Jul 14, 2026

Oncology · GIST

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Cardiology · Medical Device

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Genetic Disorders · Gaucher Disease

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Reproductive Health · Adenomyosis

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Oncology · Tyrosine Kinase Inhibitors

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Oncology · General and Metabolism · Diabetes

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Immunology · IgG4-related disease

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Endocrinology · Corticosteroid

Therapeutic area assessment

3 evidence

Updated Jul 14, 2026

Oncology · Urothelial Cancer

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Gynecology · Dysmenorrhea

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Ophthalmology · Age-related Macular Degeneration

Therapeutic area assessment

4 evidence

Updated Jul 14, 2026

Ophthalmology · Age-Related Macular Degeneration

Therapeutic area assessment

4 evidence

Updated Jul 14, 2026

Dermatology · Alopecia Areata

Therapeutic area assessment

2 evidence

Updated Jul 14, 2026

Dermatology · Alopecia Areata and Vitiligo

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Surgery · Breast Reconstruction

Therapeutic area assessment

1 evidence

Updated Jul 14, 2026

Cardiovascular · Antihypertensive

Therapeutic area assessment

9 evidence

Updated Jul 13, 2026

Dermatology · Psoriasis

Therapeutic area assessment

8 evidence

Updated Jul 13, 2026

Cardiovascular · Anticholinergic

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Psychiatry · SSRI

Therapeutic area assessment

3 evidence

Updated Jul 13, 2026

Oncology · Myeloid Cancer

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Neurology · Gene Therapy

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Cardiology · Antiplatelet

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Neurology · Carbonic Anhydrase Inhibitor

Therapeutic area assessment

3 evidence

Updated Jul 13, 2026

Oncology · CDK Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Neonatology · Bronchopulmonary Dysplasia

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Rheumatology · Rheumatoid Arthritis

Therapeutic area assessment

3 evidence

Updated Jul 13, 2026

Women's Health · Contraception

Therapeutic area assessment

6 evidence

Updated Jul 13, 2026

Neuropsychiatry · Developmental Disorders

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Endocrinology · Hormone Replacement

Therapeutic area assessment

7 evidence

Updated Jul 13, 2026

Obesity · Medical Device

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Nephrology · Light Chain Cast Nephropathy

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Neurology · Spinal Muscular Atrophy

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Hematology · RNA-targeted therapy

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Rheumatology · Gout

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Orthopedics · Shoulder Surgery

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Anesthesia · Sedation

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Oncology · Hodgkin Lymphoma

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Oncology · Targeted Protein Degradation

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Neurology · Major Depressive Disorder

Therapeutic area assessment

2 evidence

Updated Jul 13, 2026

Infectious Disease · Pneumococcal Disease

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Gastroenterology · IL-23 Inhibitors

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Pain Management · Shockwave Therapy

Therapeutic area assessment

1 evidence

Updated Jul 13, 2026

Oncology · Chemotherapy Support

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Chemotherapy Adjunct

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Cardiology · Surgical Procedures

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · High-Grade Glioma

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Infectious Disease · Antifungal

Therapeutic area assessment

3 evidence

Updated Jul 12, 2026

Electrolyte Imbalance · Calcium Supplement

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Neurology · Antidepressant

Therapeutic area assessment

4 evidence

Updated Jul 12, 2026

Neurology · Alcohol Use Disorder

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Neurology · Friedrich's Ataxia

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Cardiology · Cardiac Safety

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Acute Lymphoblastic Leukemia

Therapeutic area assessment

3 evidence

Updated Jul 12, 2026

Musculoskeletal · Knee Pain

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Pediatrics · Analgesic

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Renal · Phosphate Binder

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Smoking Cessation · Nicotine Receptor Agonist

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Neurology · Generic Drug

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Obesity · Combination Therapy

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Anesthesia · Sedative

Therapeutic area assessment

3 evidence

Updated Jul 12, 2026

Oncology · KRAS G12C-Positive Non-Small Cell Lung Cancer

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Cardiology · Acute Myocardial Infarction

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Neurology · Viral Infections

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Breast/Ovarian Cancer

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Pain Management · Analgesia

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Cardiovascular · Atherosclerotic Disease

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Pain Management · Solvent

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Immunology · Monoclonal Antibody

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Allergy · Nasal Spray

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Cardiovascular · Angina

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · PD-1 Inhibitor and ADC

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Nasopharyngeal Carcinoma

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Cardiovascular · Diuretic

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Neurology · Movement Disorders

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Oncology · Estrogen Receptor Modulator

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Immunology · Immunosuppressant

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Oncology · Early Detection

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Neurology · Pediatric Neurosurgery

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Immunology · Immunodeficiency

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Cell Therapy

Therapeutic area assessment

2 evidence

Updated Jul 12, 2026

Neurology · Friedreich's Ataxia

Therapeutic area assessment

1 evidence

Updated Jul 12, 2026

Oncology · Antiemetic

Therapeutic area assessment

8 evidence

Updated Jul 11, 2026

Ophthalmology · Ocular Surface Diseases

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Dermatology · Infantile Hemangiomas

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Oncology · HPV-related cancers

Therapeutic area assessment

4 evidence

Updated Jul 11, 2026

Oncology · HPV-related Cancers

Therapeutic area assessment

4 evidence

Updated Jul 11, 2026

Infectious Disease · Antibacterial

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Dermatology · Anti-fungal

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Pediatrics · ADHD

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Mental Health · Depression

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Hematology · Hemophilia

Therapeutic area assessment

4 evidence

Updated Jul 11, 2026

Pulmonology · Lung Fibrosis

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Cardiovascular · Abdominal Aortic Aneurysm

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Regulatory Affairs · Drug Manufacturing

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Nephrology · Chronic Kidney Disease

Therapeutic area assessment

6 evidence

Updated Jul 11, 2026

Endocrinology · Reproductive Health

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Infectious Disease · Sepsis

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Oncology · Soft-Tissue Sarcoma

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Immunology · Biosimilar

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Obesity · Neuromodulation

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Hematology · Autoinflammatory Syndromes

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Rheumatology · Still's Disease

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Hematology · Multiple Myeloma

Therapeutic area assessment

6 evidence

Updated Jul 11, 2026

Neurology · Intracerebral Hemorrhage

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Hematology · CLL/SLL and related lymphomas

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Oncology · Bone Health

Therapeutic area assessment

2 evidence

Updated Jul 11, 2026

Hematology · Immune Thrombocytopenia

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Obesity · Injectable Therapy

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Sleep Disorders · Sleep-Disordered Breathing

Therapeutic area assessment

1 evidence

Updated Jul 11, 2026

Infection Control · Medical Devices

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Oncology · Kidney Cancer

Therapeutic area assessment

3 evidence

Updated Jul 10, 2026

Urology · Male Infertility

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Hepatology · Primary Biliary Cholangitis

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Cardiology · Biomarker Research

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Oncology · Malignant Mesothelioma

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Pain Management · Chronic Coccydynia

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Immunology · Lupus Nephritis

Therapeutic area assessment

3 evidence

Updated Jul 10, 2026

Oncology · Digital Health

Therapeutic area assessment

2 evidence

Updated Jul 10, 2026

Regulatory Affairs · Drug Labeling

Therapeutic area assessment

2 evidence

Updated Jul 10, 2026

Dermatology · Atopic Dermatitis

Therapeutic area assessment

11 evidence

Updated Jul 10, 2026

Pulmonology · Idiopathic Pulmonary Fibrosis

Therapeutic area assessment

6 evidence

Updated Jul 10, 2026

Not specified · Not specified

Therapeutic area assessment

3 evidence

Updated Jul 10, 2026

Oncology · HER2+ Solid Tumors

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Obstetrics · Preterm Birth

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Oncology · Photodynamic Therapy

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Hematology · Plasma-derived Products

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Hematology · Plasma-derived therapies

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Dermatology · Actinic Keratosis

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Pulmonology · Fibrosing Interstitial Lung Disease

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Hematology · Stem Cell Transplantation

Therapeutic area assessment

3 evidence

Updated Jul 10, 2026

Oncology · Follicular Lymphoma

Therapeutic area assessment

4 evidence

Updated Jul 10, 2026

Oncology · Intrahepatic Cholangiocarcinoma

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Oncology · Dendrimer-based therapy

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Oncology · Combination Therapy

Therapeutic area assessment

9 evidence

Updated Jul 10, 2026

Endocrinology · PCOS

Therapeutic area assessment

2 evidence

Updated Jul 10, 2026

Infectious Disease · Respiratory Tract Infections

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Infectious Disease · Malaria

Therapeutic area assessment

2 evidence

Updated Jul 10, 2026

Hematology · Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Immunology · Myositis

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Gastroenterology · Enzyme Replacement Therapy

Therapeutic area assessment

1 evidence

Updated Jul 10, 2026

Neurology · Traumatic Brain Injury

Therapeutic area assessment

2 evidence

Updated Jul 10, 2026

Cardiovascular · Monoclonal Antibody

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · CDK4/6 Inhibitor

Therapeutic area assessment

6 evidence

Updated Jul 9, 2026

Diabetes · Combination Therapy

Therapeutic area assessment

2 evidence

Updated Jul 9, 2026

Anesthesia · Opioid

Therapeutic area assessment

3 evidence

Updated Jul 9, 2026

Cardiology · Antiarrhythmic

Therapeutic area assessment

3 evidence

Updated Jul 9, 2026

Immunology · Complement Inhibition

Therapeutic area assessment

4 evidence

Updated Jul 9, 2026

Oncology · Pharmacokinetics

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Hepatology · Cirrhosis

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · Gastric Cancer

Therapeutic area assessment

7 evidence

Updated Jul 9, 2026

Neurology · Muscular Dystrophy

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Ophthalmology · Intraocular Lens

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Dermatology · Topical Steroid

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Hematology · Antifibrinolytic

Therapeutic area assessment

2 evidence

Updated Jul 9, 2026

Metabolic Disorders · Levocarnitine

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Urology · 5-alpha reductase inhibitor

Therapeutic area assessment

7 evidence

Updated Jul 9, 2026

Urology · 5-Alpha Reductase Inhibitor

Therapeutic area assessment

7 evidence

Updated Jul 9, 2026

Hematology · Blood Transfusion

Therapeutic area assessment

2 evidence

Updated Jul 9, 2026

Infectious Diseases · Tuberculosis

Therapeutic area assessment

3 evidence

Updated Jul 9, 2026

Oncology · Familial Adenomatous Polyposis

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Addiction · Neuromodulation

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Infectious Disease · Coronavirus

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Mental Health · PTSD

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · Pancreatic Cancer

Therapeutic area assessment

12 evidence

Updated Jul 9, 2026

Oncology · Oncolytic Virus Therapy

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Endocrinology · GLP-1 Agonist

Therapeutic area assessment

3 evidence

Updated Jul 9, 2026

Oncology · Cancer Care

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · Head and Neck Cancer

Therapeutic area assessment

9 evidence

Updated Jul 9, 2026

Orthopedics · Femur Fractures

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Cardiology · Transcatheter Aortic Valve Replacement

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Cardiology · ATTR-CM

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Rare Diseases · Various

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · IL-1 Inhibition

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Immunology · Autoinflammatory Disorders

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Oncology · Gastroesophageal Cancer

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Cardiology · Anticoagulation

Therapeutic area assessment

2 evidence

Updated Jul 9, 2026

Pediatrics · Tracheoesophageal Fistula

Therapeutic area assessment

1 evidence

Updated Jul 9, 2026

Ophthalmology · Anti-VEGF

Therapeutic area assessment

2 evidence

Updated Jul 9, 2026

Hepatology · Ascites

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Hematology · Anticoagulant

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Dermatology · JAK Inhibitor

Therapeutic area assessment

4 evidence

Updated Jul 8, 2026

Dermatology · Topical Anti-inflammatory

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Gastroenterology · Constipation

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Psychiatry · ADHD

Therapeutic area assessment

2 evidence

Updated Jul 8, 2026

Mental Health · Digital Therapeutics

Therapeutic area assessment

2 evidence

Updated Jul 8, 2026

Hematology · Sickle Cell Disease

Therapeutic area assessment

3 evidence

Updated Jul 8, 2026

Contraception · Hormonal

Therapeutic area assessment

2 evidence

Updated Jul 8, 2026

Dermatology · Acne

Therapeutic area assessment

9 evidence

Updated Jul 8, 2026

Infectious Disease · Respiratory Syncytial Virus

Therapeutic area assessment

6 evidence

Updated Jul 8, 2026

Genetic Disorders · Mucopolysaccharidosis

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Oncology · CD30-positive Lymphoma

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Gastroenterology · Pancreatic Disorders

Therapeutic area assessment

2 evidence

Updated Jul 8, 2026

Oncology · TIL Therapy

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Diabetes · Oral Hypoglycemics

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Infectious Disease · Clostridioides Difficile Infection

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Hematology · Systemic AL Amyloidosis

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Nephrology · Immunoglobulin A Nephropathy

Therapeutic area assessment

2 evidence

Updated Jul 8, 2026

Oncology · Esophageal Squamous Cell Carcinoma

Therapeutic area assessment

3 evidence

Updated Jul 8, 2026

Oncology · Pediatric Hematology

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Cardiovascular · Statin

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Oncology · FLT3 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Oncology · Biologic Therapy

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Nephrology · Dialysis

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Oncology · Radioactive Drug Therapy

Therapeutic area assessment

1 evidence

Updated Jul 8, 2026

Infectious Disease · Nontuberculous Mycobacterial Infections

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Anesthesiology · Postoperative Nausea and Vomiting

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Cardiovascular · Cholesterol Management

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Oncology · Meningioma

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Oncology · Imaging Biomarker

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Oncology · Esophageal Cancer

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Oncology · Hematologic Malignancies and Solid Tumors

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Otolaryngology · Voice Disorders

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Respiratory · Cough and Cold

Therapeutic area assessment

3 evidence

Updated Jul 7, 2026

Endocrinology · Type 2 Diabetes

Therapeutic area assessment

9 evidence

Updated Jul 7, 2026

Analgesia · Postoperative Pain

Therapeutic area assessment

2 evidence

Updated Jul 7, 2026

Oncology · EGFR-targeted therapies

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Hematology · Myelodysplastic Syndromes

Therapeutic area assessment

3 evidence

Updated Jul 7, 2026

Oncology · Mantle Cell Lymphoma

Therapeutic area assessment

2 evidence

Updated Jul 7, 2026

Cardiovascular Disease · Pneumonia

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Gastroenterology · Crohn's Disease

Therapeutic area assessment

4 evidence

Updated Jul 7, 2026

Oncology · HCC

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Endocrinology · Primary Aldosteronism

Therapeutic area assessment

2 evidence

Updated Jul 7, 2026

Infectious Disease · Antiviral

Therapeutic area assessment

16 evidence

Updated Jul 7, 2026

Oncology · Osteosarcoma

Therapeutic area assessment

3 evidence

Updated Jul 7, 2026

Oncology · Endometrial Cancer

Therapeutic area assessment

2 evidence

Updated Jul 7, 2026

Neurology · Inclusion Body Myositis

Therapeutic area assessment

1 evidence

Updated Jul 7, 2026

Anesthesia · Pain Management

Therapeutic area assessment

2 evidence

Updated Jul 6, 2026

Rheumatology · Small Molecule

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Oncology · Immunomodulator

Therapeutic area assessment

8 evidence

Updated Jul 6, 2026

Cardiovascular · Peripheral Arterial Disease

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Oncology · HIV-related Malignancies

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

General Medicine · Injectable

Therapeutic area assessment

2 evidence

Updated Jul 6, 2026

Emergency Medicine · Data Analytics

Therapeutic area assessment

2 evidence

Updated Jul 6, 2026

Ophthalmology · Neovascular Age-related Macular Degeneration

Therapeutic area assessment

3 evidence

Updated Jul 6, 2026

Ophthalmology · Neovascular Age-Related Macular Degeneration

Therapeutic area assessment

3 evidence

Updated Jul 6, 2026

Oncology · DNA Repair Inhibition

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Neurology · SLC6A1-NDD

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Immunology · Inflammatory Disorders

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Nephrology · Kidney Transplant

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Obstetrics · AI Decision Support

Therapeutic area assessment

2 evidence

Updated Jul 6, 2026

Oncology · Pediatric Neoplasms

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Rheumatology · Monoclonal Antibody

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Hematology · Acute Promyelocytic Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 6, 2026

Endocrinology · Hypophosphatemia

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · HER2 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Hematology · CD123-targeted therapy

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Addiction · Stimulant Use Disorder

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Addiction · Psilocybin

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Mental Health · Anxiety Disorders

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Pediatrics · ECMO

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · NRAS-mutant Melanoma

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Hematology · Chronic Myelomonocytic Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Immunology · IL-4/IL-13

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Neurology · Autoimmune Diseases

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Cardiovascular · Aortic Dissection

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Neurology · Aphasia

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Sleep Disorders · Herbal Medicine

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Dermatology · Transdermal Delivery

Therapeutic area assessment

2 evidence

Updated Jul 5, 2026

Oncology · Pediatric

Therapeutic area assessment

8 evidence

Updated Jul 5, 2026

Oncology · Pediatric Cancer

Therapeutic area assessment

4 evidence

Updated Jul 5, 2026

Oncology · Pediatric Cancers

Therapeutic area assessment

2 evidence

Updated Jul 5, 2026

Genetics · Familial Mediterranean Fever

Therapeutic area assessment

2 evidence

Updated Jul 5, 2026

Nephrology · Vasopressin Antagonist

Therapeutic area assessment

2 evidence

Updated Jul 5, 2026

Oncology · Thyroid Cancer

Therapeutic area assessment

7 evidence

Updated Jul 5, 2026

Women's Health · Hormonal Therapy

Therapeutic area assessment

3 evidence

Updated Jul 5, 2026

Surgery · Thoracic

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · T Cell Non-Hodgkin Lymphoma

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Infectious Disease · Urinary Tract Infections

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · CAR T-cell Therapy

Therapeutic area assessment

5 evidence

Updated Jul 5, 2026

Ophthalmology · Diagnostic Imaging

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · Urothelial Carcinoma

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Reproductive Health · Assisted Reproductive Technology

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Cardiovascular Disease · Observational Study

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Oncology · Androgen Receptor Inhibitor

Therapeutic area assessment

2 evidence

Updated Jul 5, 2026

Autoimmune · Type 1 Diabetes

Therapeutic area assessment

1 evidence

Updated Jul 5, 2026

Immunology · IL-17

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Neurology · Psychotropic Agents

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Oncology · Surgical Robotics

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Pulmonary Hypertension · Rare Disease

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Neurology · Bipolar Disorder

Therapeutic area assessment

3 evidence

Updated Jul 4, 2026

Psychiatry · Borderline Personality Disorder

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Cardiovascular · Peripheral Artery Disease

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Not specified

Therapeutic area assessment

30 evidence

Updated Jul 4, 2026

Gastroenterology · Laxative

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Sleep Disorders · Melatonin Receptor Agonist

Therapeutic area assessment

4 evidence

Updated Jul 4, 2026

Aging · Metformin

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Addiction · Opioid Dependence

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

CNS · Cough Suppressant

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Metabolic Disorders · Urea Cycle Disorder

Therapeutic area assessment

5 evidence

Updated Jul 4, 2026

Metabolic Disorders · Urea Cycle Disorders

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Oncology · Liver Cancer

Therapeutic area assessment

4 evidence

Updated Jul 4, 2026

Hematology · Paroxysmal Nocturnal Hemoglobinuria

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Hematology · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Oncology · CAR T Cell Therapy

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Oncology · HPV Vaccine

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Cardiology · Dyslipidemia

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Addiction · Opioid Use Disorder

Therapeutic area assessment

2 evidence

Updated Jul 4, 2026

Hepatology · GLP-1 Agonist

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Endocrinology · Testosterone Deficiency

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Oncology · Gene Regulation

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Infectious Disease · Antibiotic Resistance

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Oncology · Biosimilar

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Hematology · IDH Inhibition

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Dermatology · Vascular Tumors

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Neurology · Imaging Techniques

Therapeutic area assessment

1 evidence

Updated Jul 4, 2026

Neurology · Stroke Recovery

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Neurology · Imaging Agent

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Neurology · Anesthesia

Therapeutic area assessment

2 evidence

Updated Jul 3, 2026

Cardiology · Peripheral Arterial Disease

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Oncology · Epidemiology

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Respiratory · Chronic Respiratory Disease

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Diabetes · Continuous Glucose Monitoring

Therapeutic area assessment

3 evidence

Updated Jul 3, 2026

Women's Health · Hormone Therapy

Therapeutic area assessment

2 evidence

Updated Jul 3, 2026

Nutraceuticals · Vitamin D

Therapeutic area assessment

2 evidence

Updated Jul 3, 2026

Hepatology · Rare Disease

Therapeutic area assessment

3 evidence

Updated Jul 3, 2026

Veterinary Medicine · Allergy

Therapeutic area assessment

2 evidence

Updated Jul 3, 2026

Oncology · Chemotherapy

Therapeutic area assessment

32 evidence

Updated Jul 3, 2026

Diabetes · Insulin

Therapeutic area assessment

3 evidence

Updated Jul 3, 2026

Diabetes · Insulin Delivery

Therapeutic area assessment

2 evidence

Updated Jul 3, 2026

Gastroenterology · Antidiarrheal

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Cardiology · Heart Pump

Therapeutic area assessment

3 evidence

Updated Jul 3, 2026

Neurology · Headache

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Oncology · BRAF-Mutant Melanoma

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Immunology · IL-23

Therapeutic area assessment

5 evidence

Updated Jul 3, 2026

Oncology · Hormonal Therapy

Therapeutic area assessment

17 evidence

Updated Jul 3, 2026

Oncology · HER2-positive Esophagogastric Adenocarcinoma

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Gastroenterology · Microbiota Therapy

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Oncology · Gastrointestinal Stromal Tumor

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Oncology · B Acute Lymphoblastic Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Dermatology · Cold Sores

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Oncology · Breast Cancer

Therapeutic area assessment

51 evidence

Updated Jul 3, 2026

Hematology · Telomerase Inhibitor

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Neurology · Progressive Supranuclear Palsy and Dementia

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Cardiology · Heart Transplantation

Therapeutic area assessment

1 evidence

Updated Jul 3, 2026

Cardiology · Diabetes

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Oncology · GI Cancers

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Cardiology · Imaging

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Hepatology · Sepsis-induced liver injury

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Oncology · B-cell Acute Lymphoblastic Leukemia (B-ALL)

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Infectious Disease · Antibiotic

Therapeutic area assessment

37 evidence

Updated Jul 2, 2026

Pediatrics · Pain Management

Therapeutic area assessment

3 evidence

Updated Jul 2, 2026

Hematology · Rare Blood Disorders

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Musculoskeletal · Osteoarthritis

Therapeutic area assessment

9 evidence

Updated Jul 2, 2026

Cardiology · Rehabilitation

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Surgery · Medical Devices

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Sleep Medicine · Obstructive Sleep Apnea

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Oncology · Lymphoma

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Cardiovascular · Aneurysm

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Hematology · Myeloproliferative Neoplasms

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Dermatology · Keloids

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Pediatrics · Obesity

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Oncology · RNA Modifications

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Hematology · Gene Therapy

Therapeutic area assessment

2 evidence

Updated Jul 2, 2026

Oncology · KRAS G12C NSCLC

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Oncology · KRAS G12C Non-Small Cell Lung Cancer

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Neurology · Tinnitus

Therapeutic area assessment

1 evidence

Updated Jul 2, 2026

Infectious Disease · HIV

Therapeutic area assessment

23 evidence

Updated Jul 1, 2026

Oncology · Targeted Therapy

Therapeutic area assessment

4 evidence

Updated Jul 1, 2026

Ophthalmology · Diabetic Retinopathy

Therapeutic area assessment

4 evidence

Updated Jul 1, 2026

Infectious Disease · Tuberculosis

Therapeutic area assessment

8 evidence

Updated Jul 1, 2026

Hematology · Thrombocytopenia

Therapeutic area assessment

4 evidence

Updated Jul 1, 2026

Anesthesia · Local Anesthetic

Therapeutic area assessment

5 evidence

Updated Jul 1, 2026

Ophthalmology · Atropine

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Hematology · Chronic Myeloid Leukemia

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Neuroscience · Schizophrenia

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Hematology · Iron Deficiency Anemia

Therapeutic area assessment

4 evidence

Updated Jul 1, 2026

Respiratory · Wheezing Diseases

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Psychiatry · SNRI

Therapeutic area assessment

2 evidence

Updated Jul 1, 2026

Obstetrics · Corticosteroids

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Psychiatry · Disruptive Mood Dysregulation Disorder

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Anxiety · Non-Pharmacological Intervention

Therapeutic area assessment

2 evidence

Updated Jul 1, 2026

Infectious Disease · Influenza

Therapeutic area assessment

8 evidence

Updated Jul 1, 2026

Immunology · Hereditary Angioedema

Therapeutic area assessment

3 evidence

Updated Jul 1, 2026

Oncology · Immune Checkpoint Inhibitors

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Cardiology · Gene Therapy

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Oncology · Advanced Care Planning

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Oncology · Triple-Negative Breast Cancer

Therapeutic area assessment

9 evidence

Updated Jul 1, 2026

Urology · Kidney Stones

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Cardiology · Acute Cardiovascular Disease

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Immunology · Corticosteroid

Therapeutic area assessment

7 evidence

Updated Jul 1, 2026

Dermatology · Antifungal

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Dermatology · Topical Immunomodulator

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Dermatology · Topical corticosteroid

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Hematology · Immunotherapy

Therapeutic area assessment

2 evidence

Updated Jul 1, 2026

Immunology · Autoimmune Disease

Therapeutic area assessment

2 evidence

Updated Jul 1, 2026

Immunology · Autoimmune Diseases

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Cardiovascular · Rehabilitation

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Oncology · Colon Cancer

Therapeutic area assessment

2 evidence

Updated Jul 1, 2026

Otolaryngology · Meniere's Disease

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Cardiology · Interventional Devices

Therapeutic area assessment

1 evidence

Updated Jul 1, 2026

Neurology · CGRP Inhibitor

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Oncology · AML

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Oncology · Viral Immunotherapy

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Nephrology · Diabetic Kidney Disease

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Oncology · Pediatric Brain Tumors

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Endocrinology · Graves' Disease

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Rare Diseases · Cystinosis

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Oncology · Solid Tumors

Therapeutic area assessment

13 evidence

Updated Jun 30, 2026

Addiction · Substance Use Disorders

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Psychiatry · Stress and Anxiety

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Immunology · Rare Disease

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pulmonology · Cystic Fibrosis

Therapeutic area assessment

4 evidence

Updated Jun 30, 2026

Hematology · Thrombotic Microangiopathy

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Psychiatry · Eating Disorders

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Cardiology · Beta-blocker

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Neurology · RNA-targeted therapy

Therapeutic area assessment

3 evidence

Updated Jun 30, 2026

Reproductive Health · Male Infertility

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pain Management · OTC

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pediatrics · Respiratory Disease

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pediatrics · Medical Devices

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pharmaceuticals · Compounding

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Pulmonology · Interstitial Lung Disease

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Oncology · Antibody-Drug Conjugate

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Cardiovascular · Omega-3 Fatty Acids

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Endocrinology · Acromegaly

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Endocrinology · Hormonal Therapies

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Gastroenterology · Barrett's Esophagus

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Immunology · Gene Therapy

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Hematology · Myelodysplastic Syndromes and Acute Myeloid Leukemia

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Oncology · Renal Cell Carcinoma

Therapeutic area assessment

7 evidence

Updated Jun 30, 2026

Ophthalmology · Autoimmune Disease

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Ophthalmology · Thyroid Eye Disease

Therapeutic area assessment

2 evidence

Updated Jun 30, 2026

Infectious Disease · Leishmaniasis

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Neurology · Migraine

Therapeutic area assessment

12 evidence

Updated Jun 30, 2026

Cardiovascular · Antiplatelet

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Pain Management · Botulinum Toxin

Therapeutic area assessment

1 evidence

Updated Jun 30, 2026

Neurology · Genetic Disorders

Therapeutic area assessment

3 evidence

Updated Jun 30, 2026

Surgery · Gynecology

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Urology · Stress Urinary Incontinence

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Dermatology · Skin Damage

Therapeutic area assessment

2 evidence

Updated Jun 29, 2026

Hepatology · NASH/MASH

Therapeutic area assessment

3 evidence

Updated Jun 29, 2026

Cardiology · Heart Pump Devices

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Psychiatry · Postpartum Depression

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Neurology · Cerebral Palsy and Muscular Dystrophy

Therapeutic area assessment

2 evidence

Updated Jun 29, 2026

Cardiovascular · ACE Inhibitor

Therapeutic area assessment

4 evidence

Updated Jun 29, 2026

Genomics · Sequencing Technology

Therapeutic area assessment

2 evidence

Updated Jun 29, 2026

Oncology · Genomics

Therapeutic area assessment

2 evidence

Updated Jun 29, 2026

Urology · Antimicrobial

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Neurology · CADASIL

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Urology · Neurogenic Bladder Overactivity

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Pain Management · Opioid Combination

Therapeutic area assessment

18 evidence

Updated Jun 29, 2026

Obesity · Surgical Intervention

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Nephrology · Hemodialysis

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Oncology · Rare Genitourinary Tumors

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Urology · BPH

Therapeutic area assessment

3 evidence

Updated Jun 29, 2026

Otolaryngology · Cochlear Implant

Therapeutic area assessment

2 evidence

Updated Jun 29, 2026

Urology · Kidney Stone Disease

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Addiction Medicine · Opioid Use Disorder

Therapeutic area assessment

5 evidence

Updated Jun 29, 2026

Dentistry · Periodontal Disease

Therapeutic area assessment

1 evidence

Updated Jun 29, 2026

Infectious Disease · Hepatitis B

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Cardiology · Lipid Management

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Respiratory · Severe Pneumonia

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Pain Management · Opioids

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Cardiology · Bradyarrhythmias

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Immunology · Transplant Rejection

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Oncology · Non-small Cell Lung Cancer

Therapeutic area assessment

4 evidence

Updated Jun 28, 2026

Oncology · Non-Small Cell Lung Cancer

Therapeutic area assessment

4 evidence

Updated Jun 28, 2026

Neurology · Carpal Tunnel Syndrome

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Neurology · Diagnostic Imaging

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Cardiology · Hypertension

Therapeutic area assessment

4 evidence

Updated Jun 28, 2026

Metabolic Disorders · Gut Microbiome

Therapeutic area assessment

2 evidence

Updated Jun 28, 2026

Pain Management · Opioid

Therapeutic area assessment

116 evidence

Updated Jun 28, 2026

Neurology · Cannabinoid

Therapeutic area assessment

4 evidence

Updated Jun 28, 2026

Neurology · Cannabinoids

Therapeutic area assessment

3 evidence

Updated Jun 28, 2026

Urology · Overactive Bladder

Therapeutic area assessment

3 evidence

Updated Jun 28, 2026

Neurology · Painful Diabetic Neuropathy

Therapeutic area assessment

2 evidence

Updated Jun 28, 2026

Various · Pharmaceuticals

Therapeutic area assessment

2 evidence

Updated Jun 28, 2026

Infection Control · Antiseptic

Therapeutic area assessment

2 evidence

Updated Jun 28, 2026

Oncology · Bladder Cancer

Therapeutic area assessment

13 evidence

Updated Jun 28, 2026

Endocrinology · Obesity

Therapeutic area assessment

9 evidence

Updated Jun 28, 2026

Oncology · Anal Cancer

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Oncology · Small-Molecule Therapeutics

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Neurology · Addiction

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Ophthalmology · Diabetic Macular Oedema

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Pain Management · Combination Analgesic

Therapeutic area assessment

5 evidence

Updated Jun 28, 2026

Pain Management · Combination Analgesics

Therapeutic area assessment

3 evidence

Updated Jun 28, 2026

Addiction · GLP-1 Receptor Agonist

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Oncology · Head and Neck Cancer / Prostate Cancer

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Obesity · Behavioral Intervention

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Infectious Disease · Viral Infections

Therapeutic area assessment

1 evidence

Updated Jun 28, 2026

Cardiology · Fabry Disease

Therapeutic area assessment

2 evidence

Updated Jun 27, 2026

Cardiology · Stenting

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Oncology · Cancer Vaccines

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Oncology · Biomarker Discovery

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Oncology · BRAF/MEK Inhibitors

Therapeutic area assessment

2 evidence

Updated Jun 27, 2026

Oncology · Oral Cancer

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Cardiology · Infective Endocarditis

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Hepatology · Chronic Hepatitis D

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Ophthalmology · Autoimmune Dry Eye Disease

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Neurology · Multiple Sclerosis

Therapeutic area assessment

15 evidence

Updated Jun 27, 2026

Bone Health · Osteoporosis

Therapeutic area assessment

2 evidence

Updated Jun 27, 2026

Rheumatology · Fibromyalgia

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Gastroenterology · Chronic Anal Fissure

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Cardiology · Endothelin Receptor Antagonist

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Endocrinology · Adrenal Insufficiency

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Oncology · Skin Melanoma

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Ophthalmology · Gene Therapy

Therapeutic area assessment

3 evidence

Updated Jun 27, 2026

Women's Health · Contraceptive

Therapeutic area assessment

7 evidence

Updated Jun 27, 2026

Oncology · Bone Cancer

Therapeutic area assessment

2 evidence

Updated Jun 27, 2026

Orthopedics · Osteoarthritis

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Infectious Disease · Antitubercular

Therapeutic area assessment

1 evidence

Updated Jun 27, 2026

Addiction · Alcohol Use Disorder

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Cardiology · Coronary Artery Disease

Therapeutic area assessment

2 evidence

Updated Jun 26, 2026

Gastroenterology · H. pylori Infection

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Oncology · Gene Therapy

Therapeutic area assessment

3 evidence

Updated Jun 26, 2026

Neurology · MS

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Neurology · GRIN-related Neurodevelopmental Disorder

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Obesity · GLP-1

Therapeutic area assessment

14 evidence

Updated Jun 26, 2026

Obesity · GLP-1 Agonist

Therapeutic area assessment

4 evidence

Updated Jun 26, 2026

Obesity · GLP-1 Agonists

Therapeutic area assessment

2 evidence

Updated Jun 26, 2026

Oncology · Radiation Therapy

Therapeutic area assessment

3 evidence

Updated Jun 26, 2026

Oncology · Brain Cancer

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Pulmonology · Pulmonary Fibrosis

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Neurology · Neonatal Hypoxic-Ischemic Encephalopathy

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Gastroenterology · Acupuncture

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Genetic Disorders · Enzyme Replacement Therapy

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Hematology · Mastocytosis

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Cardiology · Anticoagulants

Therapeutic area assessment

1 evidence

Updated Jun 26, 2026

Cardiology · Delirium Prevention

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Anesthesia · Ketamine

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Endocrinology · Hypertriglyceridemia

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Allergy · Anaphylaxis

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Endocrinology · GLP-1

Therapeutic area assessment

7 evidence

Updated Jun 25, 2026

Endocrinology · GLP-1/GIP Agonist

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Nephrology · SGLT2 Inhibitor

Therapeutic area assessment

4 evidence

Updated Jun 25, 2026

Nephrology · SGLT2 Inhibitors

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Neurology · Sleep-Wake Disorders

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Oncology · Colorectal Cancer

Therapeutic area assessment

34 evidence

Updated Jun 25, 2026

Infectious Disease · COVID-19

Therapeutic area assessment

15 evidence

Updated Jun 25, 2026

Immunology · Vaccine Development

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Anesthesiology · Pain Management

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Cardiology · Aortic Aneurysm

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Oncology · HPV Vaccination

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Oncology · Gynecologic Cancer

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Pain Management · Chronic Non-Cancer Pain

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Endocrinology · Type II Diabetes

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Women's Health · Endometriosis

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Nephrology · Acute Kidney Injury

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Oncology · Acute Myeloid Leukemia

Therapeutic area assessment

4 evidence

Updated Jun 25, 2026

Oncology · Fertility Preservation

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Infectious Disease · Pneumococcal Vaccination

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Oncology · PARP Inhibitor

Therapeutic area assessment

2 evidence

Updated Jun 25, 2026

Oncology · PARP Inhibitor and PI3K Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Anesthesia · Regional Anesthesia

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Hematology · CAR-T

Therapeutic area assessment

1 evidence

Updated Jun 25, 2026

Hematology · CLL/SLL

Therapeutic area assessment

6 evidence

Updated Jun 25, 2026

Immunology · Lupus and Rheumatoid Arthritis

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Addiction · Alcohol Dependence

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Ophthalmology · Eye Drops

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Infectious Disease · Respiratory Syncytial Virus (RSV)

Therapeutic area assessment

4 evidence

Updated Jun 24, 2026

Oncology · Solid Tumors and CNS Tumors

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Oncology · Burkitt Lymphoma

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Neurology · Stroke

Therapeutic area assessment

7 evidence

Updated Jun 24, 2026

Neurology · Stroke Rehabilitation

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Reproductive Health · GnRH Antagonist

Therapeutic area assessment

3 evidence

Updated Jun 24, 2026

Psychiatry · Antidepressant

Therapeutic area assessment

5 evidence

Updated Jun 24, 2026

Surgery · Infection Prevention

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Pain Management · NSAID

Therapeutic area assessment

7 evidence

Updated Jun 24, 2026

Substance Use Disorder · Opioid Use Disorder

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Cardiovascular Disease · Nutritional Assessment

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Infectious Disease · Syphilis

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Neurology · Sleep Disorders

Therapeutic area assessment

3 evidence

Updated Jun 24, 2026

Cardiology · LDL-C lowering

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Cardiology · LDL-C Lowering

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Hematology · CLL

Therapeutic area assessment

9 evidence

Updated Jun 24, 2026

Neurology · Multifocal Motor Neuropathy

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Hematology · Thalassemia

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Oncology · Surgical Care

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Oncology · Diagnostics and Multiple Sclerosis · BTK Inhibitor

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Neurology · Muscle Relaxant

Therapeutic area assessment

2 evidence

Updated Jun 24, 2026

Oncology · Thyroid Carcinoma

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Allergy · Antihistamine

Therapeutic area assessment

9 evidence

Updated Jun 24, 2026

Hematology · Acute Myeloid Leukemia

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Cardiovascular · Pulmonary Arterial Hypertension

Therapeutic area assessment

1 evidence

Updated Jun 24, 2026

Neurology · Wakefulness-promoting agent

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Sleep Disorders · Obstructive Sleep Apnea

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Genetics · Gene Therapy

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Oncology · Uveal Melanoma

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Endocrinology · Hypercalcemia

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Endocrinology · Gestational Diabetes

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Oncology · Bispecific T-cell Engager

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Neurology · Wakefulness Promoting Agent

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Endocrinology · Vitamin D Analog

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Hematology · Spleen Tyrosine Kinase Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Gastroenterology · Regenerative Therapy

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Oncology · FGFR Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Endocrinology · Dopamine Agonist

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Gastroenterology · Proton Pump Inhibitor

Therapeutic area assessment

7 evidence

Updated Jun 23, 2026

Nephrology · Monoclonal Antibody

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Cardiovascular · Beta-blocker

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Cardiovascular · Gene Editing

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Oncology · ADC

Therapeutic area assessment

14 evidence

Updated Jun 23, 2026

Mental Health · Behavioral Interventions

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Cardiology · Electrolyte Replacement

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Pain Management · Chronic Low Back Pain

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Critical Care · Catheterization

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Pain Management · Pediatric

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Pain Management · Analgesic

Therapeutic area assessment

15 evidence

Updated Jun 23, 2026

Pain Management · Analgesics

Therapeutic area assessment

5 evidence

Updated Jun 23, 2026

Immunology · Monoclonal Antibodies

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Biologics · Drug Delivery

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Obesity · GLP-1 Receptor Agonist

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Gastroenterology · Ulcerative Colitis

Therapeutic area assessment

12 evidence

Updated Jun 23, 2026

Hepatology · Chronic Liver Disease

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Orthopedics · Regenerative Medicine

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Cardiology · Pulmonary Arterial Hypertension

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Women's Health · Uterine Fibroids

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Neurology · Pediatric Demyelinating Diseases

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Oncology · Ewing Sarcoma

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Immunology · JAK Inhibitor

Therapeutic area assessment

19 evidence

Updated Jun 23, 2026

Imaging · Contrast Agent

Therapeutic area assessment

6 evidence

Updated Jun 23, 2026

Genetic Disorders · Congenital Disorders of Glycosylation

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Endocrinology · Type I Diabetes

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Respiratory · Bronchial Challenge Test

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Psychiatry · Antipsychotic

Therapeutic area assessment

19 evidence

Updated Jun 23, 2026

General · AI in Drug Development

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Endocrinology · Hypertension

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Neurology · Parkinson's Disease

Therapeutic area assessment

22 evidence

Updated Jun 23, 2026

Oncology · Small Molecule

Therapeutic area assessment

27 evidence

Updated Jun 23, 2026

Ophthalmology · Glaucoma

Therapeutic area assessment

16 evidence

Updated Jun 23, 2026

Respiratory · Asthma

Therapeutic area assessment

15 evidence

Updated Jun 23, 2026

Neurology · Infectious Disease

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Hepatology · Vasopressor

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Cardiovascular · Anticoagulant

Therapeutic area assessment

20 evidence

Updated Jun 23, 2026

Hematology · JAK Inhibitor

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Neurology · Pain Management

Therapeutic area assessment

11 evidence

Updated Jun 23, 2026

Urology · Pain Management

Therapeutic area assessment

12 evidence

Updated Jun 23, 2026

Neuroscience · Alcohol Use Disorder

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Anesthesia · Neuromuscular Blocker

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Psychiatry · PTSD

Therapeutic area assessment

5 evidence

Updated Jun 23, 2026

Cardiovascular · Medical Devices

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Ophthalmology · Diagnostic Agent

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Diabetes · SGLT2 Inhibitor

Therapeutic area assessment

12 evidence

Updated Jun 23, 2026

Pulmonary Embolism · Interventional Procedure

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Bone Health · Bisphosphonate

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Osteoporosis · Bisphosphonate

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Infectious Disease · Vaccine

Therapeutic area assessment

18 evidence

Updated Jun 23, 2026

Obstetrics · Gynecological Procedures

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Cardiology · Transcatheter Aortic Valve Implantation

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Infectious Disease · COVID-19 Vaccine

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Obesity · Small Molecule

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Oncology · Chemotherapy-Induced Peripheral Neuropathy

Therapeutic area assessment

2 evidence

Updated Jun 23, 2026

Oncology · Immuno-Oncology

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Cardiovascular · ACS

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Otolaryngology · Chronic Rhinosinusitis with Nasal Polyps

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Dermatology · Aesthetic Medicine

Therapeutic area assessment

4 evidence

Updated Jun 23, 2026

Vascular · Varicose Veins

Therapeutic area assessment

3 evidence

Updated Jun 23, 2026

Oncology · HER2-positive Gastric Cancer

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Dermatology · Skin Hydration

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Obesity · Oral Tablet

Therapeutic area assessment

1 evidence

Updated Jun 23, 2026

Infectious Disease · Antiparasitic

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Hematology · Monoclonal Antibody

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Nephrology · Pruritus

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Oncology · Data Collection

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Hematology · Acute Leukemia / Myelodysplastic Syndrome

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Respiratory · COPD

Therapeutic area assessment

13 evidence

Updated Jun 22, 2026

Neurology · Gaucher Disease and Parkinsonism

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Hepatology · Alcohol Use Disorder

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Oncology · T-cell Acute Lymphoblastic Leukemia

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Oncology · T-Cell Acute Lymphoblastic Leukemia

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Oncology · Tenosynovial Giant Cell Tumor

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Respiratory · Chronic Obstructive Pulmonary Disease (COPD)

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Veterinary Medicine · Parasitic Infections

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Anesthesia · Local Anesthetics

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Respiratory · Device

Therapeutic area assessment

2 evidence

Updated Jun 22, 2026

Neurology · Autoimmune Disorders

Therapeutic area assessment

4 evidence

Updated Jun 22, 2026

Pulmonology · Oncology

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Oncology · SCLC

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Cardiology · Heart Disease

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Hematology · cGVHD

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Dermatology · Small Molecule

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Respiratory · Nasal Spray

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Gynecology · Endometriosis

Therapeutic area assessment

3 evidence

Updated Jun 22, 2026

Gastroenterology · AI in Diagnostics

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Anesthesia · Surgical Procedures

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Neurology · Amyotrophic Lateral Sclerosis (ALS)

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Neurology · Neuroimmune Diseases

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Cardiology · Pulmonary Hypertension

Therapeutic area assessment

6 evidence

Updated Jun 22, 2026

Pulmonology · Neonatal Care

Therapeutic area assessment

1 evidence

Updated Jun 22, 2026

Oncology · Ovarian Cancer

Therapeutic area assessment

8 evidence

Updated Jun 21, 2026

Immunology · IL-5

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Women's Health · Nausea and Vomiting in Pregnancy

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Infectious Disease · Antimalarial

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Cardiology · Microvascular Health

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Anesthesia · Monitoring

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Neurology · Autoimmune Disease

Therapeutic area assessment

3 evidence

Updated Jun 21, 2026

Oncology · DLBCL

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Neurology · Neurodevelopmental Disorders

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Hepatology · Liver Fibrosis

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Rheumatology · Psoriatic Arthritis

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Oncology · CAR-T

Therapeutic area assessment

7 evidence

Updated Jun 21, 2026

Respiratory · Bronchodilator

Therapeutic area assessment

6 evidence

Updated Jun 21, 2026

Neurology · Cough Suppressant

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Cardiology · Hypertrophic Cardiomyopathy

Therapeutic area assessment

2 evidence

Updated Jun 21, 2026

Neurology · Multiple System Atrophy

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Neurology · Status Epilepticus

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Respiratory · Bronchial Provocation Testing

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Neurology · CGRP Antibody

Therapeutic area assessment

1 evidence

Updated Jun 21, 2026

Cardiovascular · Hypercholesterolemia

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Antineoplastic

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Neurology · Duchenne Muscular Dystrophy

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · mCRC

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Gallbladder Cancer

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Cardiology · ACE Inhibitors

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Endocrinology · Polycystic Ovary Syndrome

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Immunology · Systemic Lupus Erythematosus

Therapeutic area assessment

7 evidence

Updated Jun 20, 2026

Diabetes · GLP-1

Therapeutic area assessment

4 evidence

Updated Jun 20, 2026

Oncology · Melanoma

Therapeutic area assessment

16 evidence

Updated Jun 20, 2026

Cardiology · Antihypertensive

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Diabetes · SGLT2 Inhibitor and Biguanide

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Neurology · Alzheimer's Disease

Therapeutic area assessment

18 evidence

Updated Jun 20, 2026

Oncology · Cervical Cancer

Therapeutic area assessment

9 evidence

Updated Jun 20, 2026

Oncology · Lung Cancer

Therapeutic area assessment

9 evidence

Updated Jun 20, 2026

Anesthesia · Medical Devices

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Oncology · Diffuse Large B-Cell Lymphoma

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Dermatology · Autoimmune Disease

Therapeutic area assessment

3 evidence

Updated Jun 20, 2026

Hematology · Amyloidosis

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Radioconjugate

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Ophthalmology · Retinitis Pigmentosa

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Neurology · Antiepileptic

Therapeutic area assessment

44 evidence

Updated Jun 20, 2026

Neurology · Antiemetic

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Oncology · Hepatocellular Carcinoma

Therapeutic area assessment

14 evidence

Updated Jun 20, 2026

Oncology · Multiple Myeloma

Therapeutic area assessment

10 evidence

Updated Jun 20, 2026

Oncology · Metabolic Reprogramming

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Pediatrics · Malnutrition

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Oncology · Brain Metastases

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Cancer-related Fatigue

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Hematology · Immune Thrombocytopenic Purpura

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Surgery

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Infectious Disease · Antibiotic Prophylaxis

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Neurology · Opioid Overdose

Therapeutic area assessment

2 evidence

Updated Jun 20, 2026

Oncology · Medical Devices

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Oncology · Immune Checkpoint Inhibitor

Therapeutic area assessment

4 evidence

Updated Jun 20, 2026

Immunology · Type 1 Diabetes

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Immunology · Genetic Disorders

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Dermatology · Autoimmune Diseases

Therapeutic area assessment

1 evidence

Updated Jun 20, 2026

Neurology · Antihistamine

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Oncology · ALK Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Neurology · Opioid Use Disorder

Therapeutic area assessment

3 evidence

Updated Jun 19, 2026

Oncology · Skin Tumors

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Neurology · Charcot-Marie-Tooth Disease

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Cardiovascular · Vasopressor

Therapeutic area assessment

2 evidence

Updated Jun 19, 2026

Oncology · ULK1 Inhibition

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

General · Drug Development

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Genetic Disorders · Fabry Disease

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Otolaryngology · Hearing Loss

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Dermatology · Vitiligo

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Psychiatry · Pediatric Bipolar Disorder

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Oncology · NK/T-Cell Lymphoma

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Cardiology · Catheters

Therapeutic area assessment

2 evidence

Updated Jun 19, 2026

Pulmonary Hypertension · Biomarkers

Therapeutic area assessment

2 evidence

Updated Jun 19, 2026

Diabetes · Neuropathy

Therapeutic area assessment

2 evidence

Updated Jun 19, 2026

Oncology · Imaging

Therapeutic area assessment

4 evidence

Updated Jun 19, 2026

Women's Health · Menopause

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Neurology · Dysphagia

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Oncology · Non-Hodgkin Lymphoma

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Oncology · CLL

Therapeutic area assessment

6 evidence

Updated Jun 19, 2026

Oncology · CLL/SLL

Therapeutic area assessment

5 evidence

Updated Jun 19, 2026

Neurology · Rett Syndrome

Therapeutic area assessment

1 evidence

Updated Jun 19, 2026

Infectious Disease · Pneumococcal Vaccine

Therapeutic area assessment

2 evidence

Updated Jun 19, 2026

Gastroenterology · Functional Dyspepsia

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Addiction · Smoking Cessation

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Cardiology · PAH

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Infectious Disease · Bacterial Infections

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Oncology · Survivorship

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Oncology · Tyrosine Kinase Inhibitor

Therapeutic area assessment

8 evidence

Updated Jun 18, 2026

Oncology · Patient Reported Outcomes

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Oncology · Drug Development

Therapeutic area assessment

3 evidence

Updated Jun 18, 2026

Cardiology · Cardiogenic Shock

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Oncology · Monoclonal Antibodies

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Obesity · Endoscopic Procedure

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Oncology · Rectal Cancer

Therapeutic area assessment

4 evidence

Updated Jun 18, 2026

Oncology · Sarcoma

Therapeutic area assessment

3 evidence

Updated Jun 18, 2026

Oncology · Biliary Tract Cancer

Therapeutic area assessment

2 evidence

Updated Jun 18, 2026

Women's Health · Fertility

Therapeutic area assessment

1 evidence

Updated Jun 18, 2026

Endocrinology · GLP-1 Agonists

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · Solid Tumors and Hematology · AML

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Dermatology · Stem Cell Therapy

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Cardiology · Device Therapy

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Infectious Disease · Cell Therapy

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · Breast Tumors

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · Neuroendocrine Tumours

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Rheumatology · Biologic

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Obesity · Pharmacotherapy

Therapeutic area assessment

2 evidence

Updated Jun 17, 2026

Neurology · Amyotrophic Lateral Sclerosis

Therapeutic area assessment

3 evidence

Updated Jun 17, 2026

Endocrinology · Type 1 Diabetes

Therapeutic area assessment

7 evidence

Updated Jun 17, 2026

Oncology · Prostate Cancer

Therapeutic area assessment

39 evidence

Updated Jun 17, 2026

Ophthalmology · Ocular Inflammation

Therapeutic area assessment

2 evidence

Updated Jun 17, 2026

Oncology · Pancreatic Adenocarcinoma

Therapeutic area assessment

2 evidence

Updated Jun 17, 2026

Oncology · Immune-Mobilizing T-cell Receptors

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Pulmonology · Pulmonary Hypertension

Therapeutic area assessment

3 evidence

Updated Jun 17, 2026

Oncology · HER2 Positive Endometrial Cancer

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · Small Cell Lung Cancer

Therapeutic area assessment

6 evidence

Updated Jun 17, 2026

Oncology · Mesothelioma

Therapeutic area assessment

2 evidence

Updated Jun 17, 2026

Respiratory · Chronic Cough

Therapeutic area assessment

2 evidence

Updated Jun 17, 2026

Oncology · Skin Cancer

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · CNS Tumors

Therapeutic area assessment

4 evidence

Updated Jun 17, 2026

Oncology · Cervical and Vaginal Cancer

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · BCR::ABL1 Inhibition

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Ophthalmology · Retinal Diseases

Therapeutic area assessment

3 evidence

Updated Jun 17, 2026

Infectious Disease · HIV-1

Therapeutic area assessment

1 evidence

Updated Jun 17, 2026

Oncology · Digital Pathology

Therapeutic area assessment

3 evidence

Updated Jun 16, 2026

Infectious Disease · Viral and Bacterial Pathogens

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Obesity · GLP-1/GIP Receptor Agonist and Amylin Analog

Therapeutic area assessment

3 evidence

Updated Jun 16, 2026

Obesity · Oral GLP-1 receptor agonist

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Oncology · NRG1 Fusion-Positive Cholangiocarcinoma

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Cardiovascular · PCSK9 Inhibition

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Obesity · Peptide Therapy

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Oncology · Immunotherapy

Therapeutic area assessment

38 evidence

Updated Jun 16, 2026

Oncology · KRAS G12C Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Hematology · Hemophilia A/B

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Hematology · BTK Degrader

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Oncology · Hormone Receptor-positive Breast Cancer

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Oncology · RET fusion-positive lung cancer

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Oncology · NSCLC

Therapeutic area assessment

38 evidence

Updated Jun 16, 2026

Obesity · Triple Agonist

Therapeutic area assessment

2 evidence

Updated Jun 16, 2026

Oncology · ER-positive Breast Cancer

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Oncology · B-cell Malignancies

Therapeutic area assessment

1 evidence

Updated Jun 16, 2026

Oncology · Bispecific Antibodies

Therapeutic area assessment

1 evidence

Updated Jun 15, 2026

Pulmonology · Obstructive Sleep Apnea

Therapeutic area assessment

3 evidence

Updated Jun 15, 2026

Oncology · EZH2 Inhibitor

Therapeutic area assessment

1 evidence

Updated Jun 15, 2026

Hematology · Myelofibrosis

Therapeutic area assessment

1 evidence

Updated Jun 14, 2026

Oncology · Oropharyngeal Cancer

Therapeutic area assessment

1 evidence

Updated Jun 12, 2026

Oncology · Neuroendocrine Tumors

Therapeutic area assessment

1 evidence

Updated Jun 12, 2026

Anesthesiology · Pediatric Surgery

Therapeutic area assessment

2 evidence

Updated Jun 12, 2026

Dermatology · Incontinence-Associated Dermatitis

Therapeutic area assessment

1 evidence

Updated Jun 12, 2026

Psychiatry · Weight Management

Therapeutic area assessment

1 evidence

Updated Jun 11, 2026

Infectious Disease · Fungal Infections

Therapeutic area assessment

3 evidence

Updated Jun 11, 2026

Infectious Disease · Cytokine Modulation

Therapeutic area assessment

1 evidence

Updated Jun 11, 2026

Hepatology · MASLD

Therapeutic area assessment

1 evidence

Updated Jun 11, 2026

Oncology · Image-Guided Therapy

Therapeutic area assessment

1 evidence

Updated Jun 11, 2026

Neurology · ALS

Therapeutic area assessment

1 evidence

Updated Jun 10, 2026

Neurology · Antipsychotic

Therapeutic area assessment

1 evidence

Updated Jun 9, 2026

Pain Management · Local Anesthetic

Therapeutic area assessment

2 evidence

Updated Jun 9, 2026

Infectious Disease · HIV and Contraception

Therapeutic area assessment

2 evidence

Updated Jun 8, 2026

Pulmonary Arterial Hypertension · Prostacyclin Analog

Therapeutic area assessment

2 evidence

Updated Jun 6, 2026

Rare Diseases · Hypophosphatasia

Therapeutic area assessment

2 evidence

Updated Jun 3, 2026

General · Drug Safety

Therapeutic area assessment

2 evidence

Updated Jun 3, 2026

Cardiology · Surgical Intervention

Therapeutic area assessment

1 evidence

Updated Jun 2, 2026

Oncology · HER2-positive solid tumours

Therapeutic area assessment

1 evidence

Updated Jun 2, 2026

Ophthalmology · Diabetic Macular Edema

Therapeutic area assessment

1 evidence

Updated Jun 1, 2026